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Abstract 
In this thesis work, we develop optical imaging protocols for the observation of the 
nanoparticles on tissue slices in order to further link their localization and their “behaviour” 
to the biological pathological environment. Bimodal zinc and iron oxide-based MRI/optical 
nanoparticle contrast agents (Zn(Fe)O) have been synthesised with a novel azeotropic 
polyol method in glycol solvents (DEG and PG). The most potent NPs, as regard to their 
MR contrast power, have been coated with carboxymethyl pullulan, polyethylene glycol, 
carboxymethyl dextran (CMD) and fucoidan, the latter being a polysaccharide able to 
specifically bind to the vascular wall. The coated NPs were injected into rat to locate 
atherothrombosis by MRI. Then the histological slices of harvested diseased tissue were 
imaged with our homemade optical microscope. Water removal using Dean-Stark apparatus 
is a novel strategy for the synthesis of NPs in polyol solution with high yield and small size. 
The NPs show the good magnetic and optical properties at room temperature. The coated 
nanoparticles were injected into an atherothrombotic rat model to locate the thrombus by 
MRI prior to sacrifice of the animals and tissue collection for histological study by optical 
microscopy. The difference of MRI images between before and after injection with 
Fucoidan-NPs and CMD-NPs is clear. The results indicated that fucoidan-NPs are linked to 
the thrombus. Some type of microscopies, such as fluorescent microscopy, dark field 
microscopy, hyperspectral dark field microscopy and interference dark field microscopy 
have been developed for the detection of NPs in liquid medium and in the histological 
tissue. By analyzing the spectrum of every pixel and comparing to the spectrum of reference 
materials, hyperspectral microscopy can detect the presence of nanomaterial on exposed 
tissue slices, locate, identify, and characterize them. Zn(Fe)O NPs would therefore 
constitute a potential bimodal contrast agent for MRI and optical imaging. Although many 
advance optical tools have been developed, but we found it is still a challenge to identify 
reliably the NPs in the tissue. 
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Résumé 
Dans ce travail de thèse, nous développons des protocoles d'imagerie optique pour 
l'observation des nanoparticules sur des coupes de tissus afin de relier leur localisation et 
leur «comportement» à l'environnement biologique, en particulier son éventuel état 
pathologique. Nous avons synthétisé des agents de contraste bimodaux, sous forme de 
nanoparticules -NP- visibles en résonnance magnétique et en optique, à base d'oxydes de fer 
et de zinc (Zn(Fe)O) avec une nouvelle méthode de polyol azéotropique dans des solvants 
glycoliques (DEG et PG). L'élimination de l'eau à l'aide de l'appareil Dean-Stark est une 
nouvelle stratégie pour la synthèse de NP dans une solution de polyol, avec un rendement 
élevé et produisant des particules de petite taille. Les NP les plus visibles, selon leur 
contraste IRM, ont été revêtus de carboxyméthyl pullulane, de polyéthylène glycol, de 
carboxyméthyl dextrane et de fucoïdane, ce dernier étant un polysaccharide capable de se 
lier spécifiquement à la paroi vasculaire. Les NPs montrent de bonnes propriétés 
magnétiques et optiques à température ambiante. Les NP recouvertes ont été injectées dans 
un modèle de rat d’athérothrombose pour localiser le thrombus par IRM avant sacrifice et 
collecte des tissus pour étude des coupes histologiques par microscopie optique. La 
différence entre les images IRM avant et après l'injection de fucoïdane-NPs et de CMD-NPs 
est claire. Les résultats montrent que les NP recouvertes de fucoïdane sont liées au 
thrombus. Certains types de microscopies, tels que la microscopie de fluorescence, la 
microscopie en champ sombre, la microscopie hyperspectrale à champ sombre et la 
microscopie interférentielle à champ sombre ont été développés pour la détection des NPs 
en milieu liquide et dans les tissus. En analysant le spectre de chaque pixel et en le 
comparant au spectre des matériaux de référence, la microscopie hyperspectrale peut 
détecter la présence de NPs sur des coupes de tissus, les localiser, les identifier et les 
caractériser. Zn(Fe)O NPs constituerait donc un agent de contraste bimodal potentiel pour 
l’IRM et l’imagerie optique. Cependant, bien que de nombreux outils optiques avancés aient 
été développés, nous avons constaté qu'il est toujours difficile d'identifier de manière fiable 
les NP dans le tissu.  
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Introduction 
Atherothrombosis is a formation of a blood clot within an artery. The main cause 
of this pathological situation is atherosclerosis, which is a widespread disease and the 
main cause of death in the world. Despite the development of modern technologies, it is 
very challenging to detect atherosclerosis because of its silent and asymptomatic evolution. 
Atherosclerosis is also a very slow developing pathology and an early detection of this 
disease is considered as essential to improve the ability of successful treatments. 
Diagnosing atherosclerosis using magnetic resonance imaging (MRI) is a good method 
that has attracted many research interests for more than three decades. However, a 
disadvantage of the MRI is that its spatial resolution is not good enough to detect and 
discriminate details at the cellular scale, which would allow a better understanding of the 
biological phenomena. For the last 20 years, nanotechnology provided numerous 
nanosystems, namely contrast agents, dedicated to improve medical imaging with the main 
modalities: MRI, scintigraphy, CTscan, ultrasonography and optical imaging. More 
specifically, nanoparticulate systems such as iron oxide nanocrystals (USPIO) and quantum 
dots have been widely developed for MR and optical imaging. However, these nanosystems 
are devoid of biospecificity which constitutes another challenge 
This project aimed at producing a novel approach for better detection and diagnosis 
accuracy of thrombosis by combining MRI with an optical imaging technique, which 
resolution is far better than that of MRI. More precisely, a biospecific dual MR-optical 
contrast agent would be used both to localize the vascular pathological area in vivo and to 
get higher resolution images from histological slices prepared from the harvested tissues. 
In recent few years, nanoparticles (NPs) containing iron and zinc oxide having both 
magnetic and fluorescent have obtained a lot of significant attraction because of their 
potential applications. ZnO-based nanocrystals doped up to 25 wt% Fe synthesized by the 
polyol method was reported with narrow size distribution by Imen Balti [1, 2, 3, 4]. 
Following this works, we have first synthesized bimodal zinc and iron oxide-based 
nanoparticle with magnetic and optical properties using diethylene glycol and propylene 
glycol as solvents. We found that without water, the size of NPs is smaller. In the beginning, 
we tried to remove all of water by using Dean-Stark apparatus just before the starting of 
2 
chemical reactions. Because of the limitation of time, we did not investigate the complete 
influence of water over the synthesis process. This work will be continued in future projects 
in the framework of the collaboration between LPL and LVTS. 
 The most potent NPs, as regard to their MR contrast power, have been coated with 
carboxymethyl pullulan, polyethylene glycol, carboxymethyl dextran and fucoidan, the 
latter being a polysaccharide able to specifically bind to the vascular wall.  
Then the coated NPs were injected into a rat model of atherothrombosis. After 
localization with MRI, some histological sections of harvested diseased tissue were imaged 
with our homemade optical microscope. Some type of dark field microscopies, such as 
hyperspectral dark field microscopy and interference dark field microscopy have been 
developed for the detection of NPs. Some software for collecting and processing images 
have been developed. 
The manuscript is presented as follows:  
In the first part, we will briefly remind the pathological context of atherothrombosis 
and the ways to image the diseased arterial wall. We will also present some common kind of 
medical imaging modalities. For safety reasons and acceptable resolution, we chose both 
MRI and optical imaging to study the development of atherothrombosis. Some basic 
concepts of MRI and optical imaging as well as about the importance of bimodal 
MR/optical contrast agent will be presented. 
 The second chapter of the manuscript will present the synthesis of the NPs by a novel 
azeotropic polyol method in glycol solvents (DEG and PG) and their characterization, as 
well as systems, methods and models we used and developed for the imaging.  
In the third part, we introduce about the development optical system used for imaging 
histological slides. Some of works with detecting, tracking, estimating hydrodynamic size of 
the NPs with homemade software will be describe. We don’t focus to optimize 
configuration of optical system. So, we design optical system with quick installation, fast 
modification and good enough resolution image qualities. 
The imaging results are presented and discussed in the fourth chapter where the most 
potent NPs, as regard to their MR contrast power and coatings have been used for in vivo 
3 
MR imaging of thrombosis followed by optical studies on histological sections from 
harvested tissue.   
At last, after a general discussion, we will conclude about our study and we will 
suggest some perspectives. 
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1.1. Atherothrombosis 
Atherothrombosis is a formation of a blood clot within an artery because 
of atherosclerosis. It is a widespread disease, which is one of the leading causes of death 
worldwide with many serious complications such as heart attack, stroke, limb gangrene, and 
ischemia organ disease including dementia [5]. Atherosclerosis is a slow process that begins 
early in childhood and progresses asymptomatically in adult life. In some people, the 
disease grows rapidly in the age of 30s but it does not become dangerous until they reach to 
the age of 50s or 60s [6]. 
Because the evolution of atherosclerosis is very slow (over decades), an early 
detection of this disease is very important to get accurate diagnosis and successful 
treatment. However, determining the reasons of the evolution of this disease is very 
challenging. It is widely admitted that atherosclerosis starts from the damages of the inner 
wall of the artery [7]. The reasons of the damages could be high amounts of lipids and 
cholesterol in the blood, high blood pressure, diabetes mellitus, obesity, and smoking, lack 
of physical activity, metabolic syndrome, mental stress and depression [8, 9, 10]. 
The schematic evolution of atherosclerosis up to atherothrombosis depicted in Figure 
1.1 [11]  begins when lipids such as cholesterol deposit in artery wall (fat streaks). 
Gradually fat streaks evolve into plaques which growth decreases the inner diameter of the 
artery. It is an extremely complex disease, where the inflammation of the artery wall is the 
main activator leading the formation of a diseased area, namely the necrotic core, made of 
lipids, cells and cellular debris located beneath the endothelium [12, 13, 14, 11]. As blood 
flows make stress forces to the surface of the plaque, someday the plaque may break up, and 
thrombosis occurs. Thrombosis can limit or completely stop the blood flow to part of 
downstream tissues causing heart attack or stroke in the case of heart or brain respectively. 
Therefore, the treatment of atherothrombosis and the prevention of thrombosis are very 
important. For this purpose, the disease must be detected as early as possible. Nowadays, 
this is possible thanks to the development of clinical imaging techniques such as X-ray 
imaging and Magnetic resonance imaging [15]. However, if functional images can be 
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obtained, there is a need for molecular images which would highlight the biological 
processes implicated in the progression of the disease.  
 
 Figure 1.1. The development of atherosclerosis up to atherothrombosis. The evolution of 
the process is depicted from the left to the right, from the very beginning (early fat streaks 
formation) to the rupture of the atherosclerotic plaque and the thrombotic event. 
1.2. Platelets and atherothrombosis 
When the atherosclerotic vessel is ruptured, thrombogenic substances within the 
necrotic core are exposed to the blood and platelets contribute to the pathophysiologic 
process via adhesion, activation and aggregation stages [16]. At a cellular level, 
phenotypical and morphological modifications of vascular cells are observed early in 
atherosclerosis [17, 18]. Platelets represent a major link between inflammation, thrombosis 
and atherogenesis [19, 20]. Beside, activated vascular cells overexpress membrane 
glycoproteins, in particular lectins, such as E-selectin, L-selectin and P-selectin (E, L and P 
stand for endothelial, leucocyte and platelet respectively). These are glycoconjugates which 
carbohydrate moieties play a critical role such as cell-cell interactions, cell growth, 
lymphocytes trafficking, thrombosis, inflammation, host defence or cancer metastasis [21, 
22]. P-selectin, overexpressed on activated platelets, is recognized by a natural ligand 
PSGL-1 (P-selectin glycoprotein ligand-1) expressed by lymphocytes via the tetrasaccharide 
sialyl LewisX [23]. Structural features of sialyl LewisX are essential for the recognition of 
PSGL-1: the hydroxyls of L-fucosyl and D-galactosyl, carboxylic group of sialic acid [24], 
and sulfated tyrosines in the protein backbone [25, 26]. 
Fucoidan, heparin and dextran sulfate are sulfated polysaccharides which bind to P-
selectin [27, 28, 29, 30] mimicking the interaction with PSGL-1. Low molecular weight 
fucoidan was formerly demonstrated to be of potential interest for revascularization in 
cardiovascular diseases [31, 32, 33] and found as the most efficient glycosidic ligand of P-
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selectin in purified system and in human whole blood experiments [27, 34, 35, 36, 37]. The 
large amount of P-selectin in platelet-rich thrombi formed after atherosclerotic plaque 
rupture or erosion makes it a good target for fucoidan. 
In this context, P-selectin appears as a good candidate target for the diagnosis of 
atherothrombosis and a contrast agent able to bind to P-selectin, i.e. vectorised by fucoidan 
to activated platelets, would efficiently enhance the detection of early thrombus formation. 
1.3. Medical imaging modalities 
Medical imaging refers to several different technologies that are used to view the 
human body in order to diagnose, monitor, or treat medical conditions. Each type of 
technology gives specific information about the area of the body being studied or treated, 
related to a possible disease, injury, or the effectiveness of a medical treatment [15, 38]. 
Depending on the desired diagnostic information, the body can be observed by the 
following common techniques: 
1.3.1. X-ray projection imaging 
X-ray imaging is one of the first medical imaging modality. It found its way into 
medical practice shortly after the discovery of X-rays in 1895 by Wilhelm Röntgen, a 
German professor of physics. Today X-ray imaging is still one of the most commonly used 
forms of medical imaging. Because it became a big industry, equipment is relatively 
inexpensive and years of software improvements lead to a fast imaging procedure. 
X-rays are created by bombarding a tungsten target with high-energy electrons inside 
an X-ray tube. When imaging with X-rays, the X-ray beam passes through the body. On its 
way through the body, parts of the energy of the X-ray beam are absorbed. The denser the 
tissues, the more X-rays are attenuated. For example, X-rays are attenuated more by dense 
bone than by soft lung tissue. On the opposite side of the body, detectors or a film capture 
the attenuated X-rays and a 2D image is produced.  
1.3.2. Computed tomography 
In 1979 G.N. Hounsfield and A.M. Cormack were awarded the Nobel Prize in 
Physiology or Medicine for the invention of computed tomography (CT). This technique 
uses computers to combine many X-rays slices to reconstruct a two- or three-dimensional 
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absorber map. Furthermore, the contrast of the computed image is software-enhanced and is 
much higher than that of a simple X-Ray projection imaging system [39]. 
Hounsfield's original CT scan prototype took several hours to acquire one single slice 
of image data and more than 24 hours to reconstruct this data into an image [40]. Today, 
many advances have been made in contrast, image quality, spatial resolution, and 
acquisition time. The modern clinical CT scanners can produce a 2D cross-sectional image 
in less than a second and reconstruct the image instantly – i.e., during the time the patient 
stays in the machine. Spatial resolution can be as low as 100 μm in-plane. However, clinical 
CT scanners are expensive, ranging in the millions of dollars, preventing a widespread 
adoption [15, p. 37].  
1.3.3. Nuclear imaging 
Nuclear imaging uses small amounts of isotopes called radiotracers that are typically 
injected into the bloodstream, inhaled or swallowed. Gamma-rays from the radiotracer are 
detected by a special camera and computed images of the distribution of radiotracers inside 
the body are obtained. 
Three-dimensional reconstruction technologies in nuclear imaging are single-photon 
emission computed tomography (SPECT), or positron emission tomography (PET). Both 
methods have a significantly lower resolution than CT with voxel sizes not much smaller 
than 1 cm3. 
In many centers, nuclear medicine images can be superimposed on CT or magnetic 
resonance imaging (MRI) images to produce special views, a practice known as image 
fusion or co-registration. These views allow the information from two different exams to be 
correlated and interpreted on one image, leading to more precise information and accurate 
diagnoses [15]. 
1.3.4. Ultrasound imaging 
Ultrasound imaging uses high-frequency sound for creating pictures of the inside of 
the body. The high-frequency (MHz) sound waves generated by a probe propagates into the 
body. The transducer collects echo of the sounds and a computer then uses those data to 
create an image. The depth of an echogenic object can be determined by the travel time of 
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the echo. The intensity of image relies on the intensity of the echo. The data is instantly 
processed and displayed by a computer. 
Because ultrasound machines are cost-effective and of small size, they are widely used 
in hospitals or in physicians’ offices. However, an ultrasound exam requires the presence of 
an experienced operator to adjust various parameters for optimum contrast, and ultrasound 
images usually require an experienced operator to interpret the image [15]. For standard 
clinical ultrasound, sound wave frequencies cover a wide range (3 – 40 MHz) and yield 
spatial resolution of 0.1 to 1 mm. The higher resolution of 0.015 to 0.02 mm has been 
achieved with ultrasound frequency of 100 MHz. However, the high frequency ultrasound is 
strongly attenuated in biological tissues. Therefore, the imaging depth is only a few 
millimetres [41, 42]. 
1.3.5. Magnetic resonance imaging 
Magnetic resonance imaging (MRI) is used in radiology to form pictures of the 
anatomy and the physiological processes of the body. Using strong magnetic fields, radio 
waves, and field gradients, MRI scanners can generate images of the organs in the body. 
MRI does not involve ionizing radiations, so it is a lot safer for operator and the studied 
patients except for people with irremovable metal implants because of eddy currents in 
conductors. MRI is based on nuclear magnetic resonance (NMR) in which certain atomic 
nuclei such as hydrogen atoms are able to absorb and emit radio frequency energy when 
placed in an external magnetic field. Hydrogen atoms exist naturally in all of biological 
organisms, particularly in water and fat. For this reason, MRI can image the whole body 
[43]. 
MRI requires a very strong and uniform magnetic field. The field strength of the 
superconducting magnets used in commercial MRI systems is between 0.2 and 7 Tesla. The 
world's currently strongest MRI Machine (21.1 T) is in Florida, USA [44]. 
1.3.6. Optical imaging 
Optical imaging is the use of light to study images of organs and tissues as well as 
smaller structures, including cells and even molecules. Images are generated by using light 
range from ultraviolet to near infrared. Many techniques have been developed for optical 
imaging: 
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Fluorescence imaging: As its name says it, fluorescence imaging uses fluorescence 
(fast emission) and phosphorescence (longer times) to study properties of organic or 
inorganic substances. When materials absorb light or other electromagnetic radiation, the 
materials may emit light back. Excited atoms or molecules in the material may return to 
their ground state through a radiative path. Normally, light isn’t the sole component of the 
deexcitation path and thus the wavelength of emission light is longer than that of excitation 
light. Shorter wavelength can be generated if more than one photon contributed to the 
molecule’s excitation. Some optical filters can, and frequently should, be added to block 
excitation light: as fluorescence has usually a low efficiency, excitation wavelength 
scattering may be too intense. The emitted fluorescence can be recorded by a detector for 
imaging. Fluorescence imaging can be used to detect molecules at small concentrations with 
a good signal-to-noise ratio if nothing else emits anything in the same wavelength range. A 
basic fluorescence imaging system is simple; however, a lot of complicated designs have 
been made to get better resolution of the fluorescent images, such as confocal microscopy 
and super resolution microscopy [45, 46, 47, 48]. 
Second harmonic imaging: in this technique, a high power and very short pulsed 
laser (femtosecond or picosecond) is focused into the sample. Ti-Sapphire (TiSa) lasers are 
frequently used for this application. The pulse width of Ti-Sapphire laser is between 10 fs to 
a few ps, with a possible spectral tuning range of ≈ 650 nm to 1100 nm [49]. These 
wavelengths penetrate deeply inside biological tissues, and short pulses give a very high 
light intensity while keeping the average power low enough. Commercially available TiSa 
lasers are now reliable and they can be operated very easily. This technique is based on the 
optical effect of second harmonic generation (SHG), whereby laser light passing through 
molecules with a non-centrosymmetric structure (ie with no centre of symmetry) leads to the 
generation of light at exactly half the wavelength of the incident light. Some well-ordered 
biological materials such as collagen, muscle myosin and microtubules can be imaged in 
this way without the need for additional labelling [50, 51]. By combining SHG with a 
confocal microscopy, one can obtain three dimensional images of biological tissues [52, 
53]. 
Optical coherence tomography: Optical coherence tomography (OCT) is a technique 
for obtaining sub-surface images such as diseased tissue just below the skin. OCT uses low-
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coherence interferometry, typically Michelson type, to produce a two-dimensional image of 
optical scattering from internal tissue microstructures in a way that is analogous to 
ultrasonic pulse-echo imaging. OCT is sensitive to scattering, thus it is mostly useful for 
tissues which aren’t too optically dense. Tomographic imaging is demonstrated in vivo in 
the peripapillary area of the retina examination [54, 55, 56]. Light in an OCT system is 
broken into two arms as we expect in a Michelson interferometer: a sample arm (containing 
the item of interest) and a reference arm (usually a mirror). The combination of reflected 
light from the sample arm and reference light from the reference arm gives rise to an 
interference pattern, but only if light from both arms have travelled the "same" optical 
distance ("same" meaning a difference smaller than a coherence length). By scanning the 
mirror in the reference arm, the length of reference arm is changed. Areas of the sample that 
reflect back a lot of light will create greater interference than areas that don't. Any light that 
is outside the short coherence length will not interfere. By analyzing interference pattern, a 
reflectivity profile of the sample can be obtained [57]. 
Photoacoustic imaging: During photoacoustic imaging, high-repetition-rate laser 
pulses are delivered into biological tissues. A part of laser energy is absorbed and converted 
into heat, leading to transient thermoelastic expansion, and generating ultrasounds. The 
generated ultrasonic waves are detected by ultrasonic transducers and then analysed to 
produce images. Since deposited optical energy is, by definition, a function of the 
absorption coefficient, this is a way get a volume image of the absorption coefficient. The 
oxygenated or not oxygenated hemoglobin is the main absorber in the near infrared region. 
This makes this technique useful for medical purposes.  
1.3.7. Conclusions 
All of the medical imaging methods (X-ray projection imaging, computed tomography 
nuclear imaging, nuclear imaging, ultrasound imaging, magnetic resonance imaging and 
optical imaging) are used very commonly. However, all of them have some drawbacks. The 
X-ray projection imaging, computed tomography nuclear imaging and nuclear imaging 
(scintigraphy) are rather dangerous for patients who undergo repetitive examinations. The 
ultrasound imaging is safe but its resolution is not good enough. MRI is a good candidate 
for atherothrombosis detection because of it is safe and it offers a good tissue resolution. 
Then, optical imaging can be used to study finer structures of diseased areas with cell 
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resolution. We compare all of medical imaging method with their main advantages and 
drawbacks in Table 1.1 [58, 59, 60]. 
Table 1.1. Comparison of medical imaging methods 
Types Resolution Sensitivity Advantages Drawbacks 
X-ray 100 μm 0.16 Cheap, fast Danger 
CT 100 μm 0.67 3D imaging Danger, 
expensive 
Nuclear 1 cm 0.60 3D imaging Danger 
MR 100 μm 0.81 Safe Expensive 
Ultrasound 100 μm 0.55 Safe, cheap Difficult in 
use 
Optical 0.2-10 μm 0.94 Safe, cheap Invasive 
 
1.4. MRI contrast agent 
MRI contrast agents are used to improve the visibility of internal body structures 
studied in MRI. Their main effect is the shortening of the longitudinal or transversal 
relaxation times, T1 or T2 respectively, of the hydrogen nuclei of neighbour water molecules. 
The capability of shortening the T1 and T2 relaxation times is described by the term 
"relaxivity". The relaxivities associated to the longitudinal and transversal relaxation rates, 
1/T1 and 1/T2, are denoted by r1 and r2.  
1.4.1. Relaxivity 
MRI contrast agents are characterized by their relaxivity. The relaxivity of an MRI 
contrast agent shows the change of relaxation rates as a function of solution 
concentration[C]. There are two corresponding relaxivities, r1 and r2 which are calculated as 
equation 1.1 and 1.2.  
ଵ
భ்
= 𝑟ଵ × [𝐶]          (1.1) 
ଵ
మ்
= 𝑟ଶ × [𝐶]         (1.2) 
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where:   T1 and T2 are relaxation rates (s), 
   [C] is the concentration of solution (mM),  
r1 and r2 are relaxivities (mM-1s-1). 
The relaxation rates of a MRI contrast agent in solution are obtained by linear fitting 
relaxation rates (1/T1) and (1/T2) versus different concentrations. The slopes of the lines 
present r1 and r2 [61, 62, 63]. 
1.4.2. T1 contrast agent  
Because of high paramagnetic moment, Gadolinium ion (Gd3+) is the most common T1 
contrast agent used in clinical applications. However, like most free ion metals, the free ion 
Gd3+ is toxic for living tissue. Therefore, in order to use it as a contrast agent, gadolinium 
ions need to be grafted on a suitable ligand to form a nontoxic complex. The relaxation 
mechanism of a T1 contrast agent is described by the Solomon-Bloembergen-Morgen 
(SBM) theory [64, 65, 66]. The relaxation is mainly due to the interaction between a Gd3+ 
ion and nearby water molecules, which directly coordinate with the Gd3+ ion. This 
interaction is characterized by the exchange correlation time τm. In the complex, Gd3+ 
usually has one directed coordination with a water molecule. The rotation of the complex is 
also important: The rotation frequency of Gd complexes is faster than the Larmor 
frequency. The effect of the complex rotation is characterized by the rotational correlation 
time τr. The slowing down of complexes close to the Larmor frequency improves the 
relaxation. One way to improve this relaxation is to link many Gd chelates on a single 
macromolecule. The consequences are both the longer rotational correlation time and the 
local increase in the concentration of Gd3+ ions [67]. 
1.4.3. T2 contrast agent  
Magnetite (Fe3O4) or maghemite (γ-Fe2O3) NPs are superparamagnetic contrast agents. 
They are the most effective T2 contrast agents [68, 69]. With their size ranging from 4 nm to 
50 nm, the superparamagnetic agents contain thousands of paramagnetic Fe ions (Fe2+ 
and/or Fe3+). Therefore, exposed to an external magnetic field, superparamagnetic agents 
induce strong local fields, which speed up the dephasing of the neighboring water protons 
[70], i.e. making a shortening of T2 and an increment of r2. Depending on their size, crystal 
structure and coating, the superparamagnetic agents are classified into superparamagnetic 
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iron oxide particles (SPIO), ultra-small superparamagnetic iron oxide particles (USPIO), 
very small superparamagnetic iron oxide particles (VSOP), monocrystalline iron oxide 
particles (MION) and cross-linked iron oxide particles (CLIO) [71, 72, 73, 74]. SPIO and 
USPIO contrast agents have been successfully used for MR images enhancement [75, 76].  
1.5. Zinc oxide 
Zinc oxide is widely used as an industrial additive to produce many materials such as 
rubbers, plastics, ceramics, concrete, glass, lubricants, paints, ointments, adhesives, sealants, 
pigments, foods, batteries, laser diodes, light emitting diodes, spintronics, solar cells, 
sensors and actuators [77]. 
Zinc oxide usually crystallizes in three different forms: hexagonal wurtzite, cubic zinc 
blende and cubic rocksalt. The ZnO wurtzite, which is the most common structure of ZnO 
[78], has the highest thermodynamic stability among the three above structures. 
Zinc oxide is a direct gap semiconductor with Eg = 3.4 eV. It has many excellent 
properties such as a good transparency, high electron mobility, wide band gap, and good 
room-temperature luminescence [79]. ZnO produces UV emission around 370 nm and 
visible emission of around 510 nm [80, 81, 82]. For the visible emission, many point defects 
have been suggested, including oxygen vacancies, interstitial oxygen, antisite oxygen, zinc 
vacancies, zinc interstitials, and surface states [83]. There are two popular mechanisms, 
which explant this visible emission: the recombination of an electron from the conduction 
band (CB) with a hole in a deep trap [84] and the recombination of holes from the valence 
band with a deeply trapped electron [85]. 
Semiconductor quantum dots (QD) have been used for biological imaging since 1998 
[86, 87]. However, the traditional QDs, like CdSe and CdTe, are toxic. Cytotoxicity of 
quantum dots used for in vitro cellular labelling have been investigated [88, 89, 90]. In 
contrast to QD, zinc oxide is categorized as a non-toxic material because it does not cause 
skin and eye irritation and there is no evidence of carcinogenicity, genotoxicity and 
reproduction toxicity in humans [91]. Luminescent ZnO NPs, due to their special 
advantages, such as bright emission, low cost, and good biocompatibility, is a better 
candidate in biological applications [92, 93]. Although the ZnO NPs have been used for cell 
imaging successfully [94, 95, 96], we still have to overcome many challenges. First, because 
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of their broad emission band, the fluorescence spectra overlap the autofluorescence of 
biological cells [97]. Secondly, UV light is used for excitation because ZnO is a wide-
bandgap semiconductor. However, UV light is not suitable for deep tissue imaging in vivo 
because cells strongly absorb light in UV band. In addition, UV light kills cells, tissues, and 
live animals, damaging their DNA [98, 99]. Therefore, multi-photon or fluorescence 
lifetime imaging may solve the above problems but add complexity to the setup. 
1.6. Bimodal MRI/optical contrast agents 
MRI contrast agents, like all contrast agents, are used for image enhancements. Many 
studies on human and animals have been performed using MRI. The method has many 
advantages, however, it has some drawbacks too. The first one is its spatial resolution. The 
spatial resolution of a commercial MRI machine is around one hundred micrometres [100, 
101, 102] and this resolution requires a long acquisition time. This limited resolution is not 
suitable for analysing the distribution of the MRI agents in small volumes such as a single 
cell or the layers of a small artery wall. The resolution of MRI is far worse than the 
resolution of an optical microscopy (~100 times). Many efforts to synthesize fluorescent 
MRI agents were proposed in order to advance the art. For example, fluorophores linked 
with MRI agents have been synthesized [103, 104]. However, autofluorescence of 
biological tissues and the main fluorophores used for agents have overlapped wavelengths 
bands, making it sometimes difficult to interpret the images. Hence, some fluorescent 
markers emitting in the near infrared region have been studied, in order to stand out of the 
autofluorescence of the tissues [105]. Another approach is to use long fluorescence lifetime 
emission by the use of lanthanide complexes. Europium and terbium, lanthanide compounds 
have been employed for forty years in analytical biochemistry [106, 107] with several 
advantages compared to purely organic fluorophores such as a very long luminescence 
decay (some hundred microseconds to some milliseconds), better photostability, narrow 
emission lines and large Stokes shift [108, 109]. The fluorescent emission lies in the visible 
domain: green light for terbium and red light for europium [110]. Within a time resolved 
microscope system, this emission can be easily discriminated from the autofluorescence 
noise. Gadolinium, europium and terbium have close physicochemical properties. By 
replacing Gd3+ ions with Eu3+ or Tb3+ ions, the same agents could possibly be used in MRI 
and in a time-gated fluorescence microscopy in the visible band. Unfortunately, the organic 
Chapter 1. Bibliography 
15 
fluorophores and lanthanide complexes are toxic needing a complexing chemical structure 
to protect the organism. Recently, a macromolecular complex bearing both terbium and 
gadolinium ions have been used to image thrombosis in a rat model [111]. However, these 
structures are not easy-to-handle. 
In recent years, nanoparticles (NPs) containing iron and zinc oxide showing both 
magnetic and fluorescent properties have attracted significant research interests because of 
their potential applications. NPs base on ZnO have been synthesized by many ways. The 
most popular approach is polyol method. Different structures such as core@shell systems 
based on ZnO and superparamagnetic iron oxide like ZnO@Fe3O4 [112] and Fe3O4@ZnO 
[113, 114], ZnO nanorods decorated with γ-Fe2O3 have been proposed [2]. ZnO-based 
nanocrystals doped with up to 25 wt% Fe synthesized by the polyol method was also 
reported with narrow size distribution (17–21 nm) [3].  
1.7. The biospecificity of contrast agents  
The response of the reticuloendothelial system (RES, mainly liver and spleen) to 
foreign particles is influenced by particle size, charge, shape and the nature of the surface. 
Particles less than 5 nm are rapidly cleared from the circulation through extravasation or 
renal clearance [115, 116]. As particle size increases, accumulation occurs primarily in the 
liver, the spleen and the bone marrow. The first process that occurs when NPs are exposed 
to plasma is a quick and massive non-specific protein adsorption which results in the 
formation of a protein corona around the material [117, 118]. Among the adsorbed proteins, 
opsonins trigger the complement activation and a signalling cascade leading in phagocytosis 
via RES. Eventually this results in non-ideal biodistribution and unpredictable 
pharmacokinetics of the NPs. This phenomenon is considerably attenuated when the 
average hydrodynamic diameter of the NPs does not exceed a hundred nanometers and 
when their surface is coated with low fouling polymers (e.g. polyethylene glycol (PEG)) 
which ensure the formation of a repulsive hydration shell limiting the protein adsorption 
[119]. In the majority of cases, NPs achieve their effects through passive targeting, which 
relies on non-specific accumulation in diseased tissue, usually tumours. Within the tumour 
microenvironment, the endothelial paving of the vessels is disjoint allowing the paracellular 
diffusion of NPs whose dimensions do not allow the passage of a healthy endothelium. This 
permeability of blood vessels in combination with poor lymphatic drainage or transport 
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leads to NPs accumulation within the diseased area: this phenomenon is defined as the 
Enhanced Permeability and Retention (EPR) effect. 
In our research, we adopt polyol method to synthesize NPs, because the size of 
synthesized NPs is less than 100 nm. This small size will limit their catch by the immune 
system, allowing a longer blood circulation time. 
1.8. Strategy of the project 
In this project, we develop imaging tools for the observation of arterial wall thrombus 
at cellular and molecular scales for better understanding of processes involved in the 
development of thrombotic diseases. This work is divided in two main parts: the preparation 
of biospecific nanoprobes endowed with magnetic and optical relevant properties, and the 
development of optical imaging methods to effectively recover injected nanoparticles in 
tissue sections, to interpret their distribution and location in relation to the pathological 
environment.  It is not any type of nanoparticle that can be used for this objective. These 
must comply with precise specifications: (i) the materials used must lead to nanostructures 
with relevant magnetic and optical properties; for this study we have prepared nanoparticles 
based on Zn(Fe)O crystals, (ii) the size of the colloids formed by the inorganic core and its 
hydrophilic hemocompatible coating must be as small as possible at the nanometric scale to 
limit an early elimination once injected into the blood; (ii) the colloids must be stable in a 
physiological medium for the duration of their use; (iii) the method of preparation must 
efficiently provide simple nanostructures. 
We synthesized our NPs without water using an azeotropic polyol synthesis method 
with the objective to study the role of water over the synthesis. Surprisingly, the absence of 
water led to smaller NPs with a tighter size distribution than with water and in higher yields. 
We have thus focused our works on the preparation of the NPs with this novel method. The 
nanocrystals have been coated with hydrophilic polymers compatible with use in a murine 
model of atherothrombosis, in particular with a polysaccharide recognized as a ligand 
specific for the thrombus. MR imaging was performed in a rat model of atherothrombosis 
and histological sections of tissues were examined with dedicated optical microscope setup. 
In a first step, we have explored in vitro optical imaging strategies using as-prepared 
nanosystems. As many techniques were available, some of them being quite sophisticated 
and expensive, we have chosen to keep the experiments as simple and straightforward as 
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possible. We added complexity gradually as needed. Then at the end of this work, when we 
built enough confidence in the setup, we applied the different optical imaging modalities to 
histological slices. 
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Chapter 2. Chemistry 
During this study, we prepared a large number of samples. The specifications 
explained previously led us to focus on a novel polyol strategy. To help the reader to 
understand our entire approach, we have chosen to focus on the main results obtained with 
nanoparticles prepared under azeotropic conditions. Other avenues have been explored, 
which are briefly presented as appendixes to the main document. Indeed, only the polyol 
azeotropic method has made it possible to quantitatively and efficiently obtain nanocrystals 
of controlled composition in zinc and iron, which made it possible to carry out studies in 
MRI and optical microscopy. The novelty of the azeotropic synthesis led us to gather our 
results for a publication in Chemical Communications which will be submitted soon. 
Thus, we have prepared Zn(Fe)O NPs with different Fe ratios (RFe = Fe/(Zn+Fe) = 0, 
0.05, 0.10, 0.15, 0.20, 0.35 and 0.50) from azeotropic distillation with toluene. We 
investigated the morphology, crystallinity, and magnetic properties of Zn(Fe)O NPs using a 
transmission electron microscope, X-ray diffraction, and a vibrating sample magnetometer. 
We coated our NPs with carboxymethyl pullulan, polyethylene glycol, fucoidan, and 
carboxymethyl dextran (CMD), but only the two latter coatings are presented in this chapter 
since the corresponding NPs could be used for animal experiments. Physicochemical 
properties of the colloids have been determined as well as magnetic and optical capacities. 
The following notations will be applied in the following: 
+ Bare NPs obtained in diethylene glycol with RFe = X will be noted: RFe, i = X. 
(ex: RFe, i = 0.50) 
+ Fucoidan-coated or CMD coated NPs with RFe =X will be noted: fuco-X or CMD-X. 
(ex: fuco-0.50) 
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2.1. Materials and methods 
2.1.1. Synthesis of NPs 
Chemicals  
Zinc acetate dehydrate (98%, Sigma Aldrich) and iron II acetate (97%, Strem 
Chemicals) were used as precursors. Diethylene glycol (99%, Alfa Aesar), polyethylene 
glycol (98%, Alfa Aesar) and toluene (99%, Alfa Aesar) were used as solvent. 
Carboxymethyl dextran was purchased from Sigma Aldrich (MW = 10-20 KDa, and CM 
content = 1.1-1.5 mmol CM/g). Carboxymethyl pullulan was prepared from pullulan 
(Hayashibara, Japan) as described in the Appendix F. Low molecular weight fucoidan from 
the brown seaweed Ascophyllum nodosum was purchased from Algues & Mer (Ile 
d’Ouessant, France). Fucose and sulfate contents were 30.1 ± 0.6 and 26.5± 0.5 respectively 
(%w/w) with Mn = 7,200 g/mol and Mw = 10,100 g/mol. Purified water used for the 
experiments was obtained by ion-exchange from running tap water (Millipore, USA). 
Preparation of bare NPs 
 We used the following protocol to prepare the nanoparticles used later in animal 
experiments. The variants of this protocol that were made with other conditions, especially 
in the presence of water, are presented in the Appendix D. In absence of water NPs we have 
obtained smaller NPs in higher yields and with a tighter size distribution. Zinc acetate and 
iron II acetate were used as precursors. Diethylene glycol (DEG), propylene glycol (PG) and 
toluene were used as solvents. 
0.02 mol of zinc acetate and iron II acetate with different Fe/Zn ratio (mol/mol) (RFe = 
Fe/(Zn+Fe) = 0, 0.05, 0.1, 0.15, 0.20, 0.35 and 0.50) were dried at 60°C under vacuum 
overnight.  Then salts were dispersed in a mixture of 80 ml of DEG (or 80 ml of PG) and 
120 ml of toluene, in a three necks 500 mL round bottom flask and heated under nitrogen 
and a gentle mechanical stirring. The flask was connected to a Dean-Stark apparatus for 
entrapping water azeotropically (Figure 2.1). For 1 h, water (a few mL) and toluene (120 
mL) were successively collected by reflux into the Dean-Stark trap and fully eliminated 
through a Teflon tap. During this process, the temperature did not exceed 110°C. Collection 
was stopped when the temperature started to rise again reaching 240°C (or 180°C with PG). 
The mixture was heated at 240°C (or 187°C with PG) for 4 additional hours (or 2 additional 
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hours with PG). After cooling down to room temperature, NPs were quantitatively collected 
by centrifugation (8000 RPM, 15 minutes) and washed 2 times with acetone, 2 times with 
ethanol and kept as a concentrated suspension in absolute ethanol. 
 
Heater
Distilling trap
Condenser Water out
Water inStirring
N2 in
Temperature controller
240 oC
Dean-Stark apparatus
 
Figure 2.1. Experimental setup for synthesis of NPs with Dean-Stark apparatus. 
2.1.2. Iron concentration measurement by UV-visible spectrophotometry 
The iron concentration was measured as follows: 10 µL of NPs suspended in water 
were mixed with 100 µl of HNO3 7 M and 100 µl of H2O2 20%. The mixture was heated to 
80oC for 2 hours. After cooling to room temperature, 1 mL of water and 100 µL of KSCN 2 
M were added to the tube just before each measurement. The iron concentration of diluted 
solution was determined by absorption spectra at 477 nm with a JASCO V-630 UV-visible 
spectrophotometer (JASCO, Germany). The concentration of Fe (𝐶ி௘) in diluted solution is 
calculated by the equation 2.1. 
𝐶ி௘ =
஽ା଴.଴଴ହହ
଻ଷଶଶ.ଷ଻଻
(mol/l)          (2.1) 
where: D is the absorption at 477 nm. 
Then the concentration of Fe in the original suspension is calculated from the value of 
𝐶ி௘  and the dilution factors. 
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2.1.3. Iron and zinc concentration measurement by AAS 
The chemical composition of the powders was obtained from suspension (0.5M) by 
atomic absorption spectroscopy (AAS) with a Perkin-Elmer Analyst 100 apparatus (Perkin-
Elmer, USA) after degradation of the nanocrystals in boiling HCl (35%). 
2.1.4. Coatings 
Fucoidan coating 
3 mL of suspension were prepared as following: 1 mL of bare NPs (RFe = 0.05, 0.15, 
0.35, 0.50) in HCl 10-2M ([Fe] = 0.12 mol/L) was diluted in 14 ml of HCl 10-2M (pH=2) and 
sonicated for 30 minutes (SA). Then 4 mg of fucoidan were dissolved in 15 ml of water 
(SB). SA and SB were mixed and gently shaken at room temperature for 2 hours. The 
fucoidan coated NPs were collected by centrifugation (7300 RPM, 30 minutes) and 
resuspended in 3 ml solution of glucose 5% (w/w). The pH of final suspension was adjusted 
to 7.2 and 7.5 with a few drops of diluted NaOH. The suspension was split into 6 tubes of 
0.5 ml each which were kept in the dark at -20oC. 
Polyethylene glycol coating 
2 mL of suspension were prepared as following: 0.667 mL of RFe, i = 0.50 NPs in HCl 
10-2M ([Fe] = 0.12 mol/L) was diluted in 3 ml of HCl 10-2 M (pH=2) and sonicated for 30 
minutes (SA). Then 50 mg Polyethylene glycol (PEG) was strongly sonicated in 10 ml of 
HCl 10-2 M (pH=2) for 2 hours (SB).  
SA was added drop by drop into SB under stirring. After stirring for 2 hours at room 
temperature, the pH of the suspension was adjusted to 7 by adding a few drops of NaOH 0.1 
M. The PEG-NPs then were washed to remove ungrafted PEG by filtration (filtration device 
with 30 kDa cut-off membrane) at 3900 RPM for 15 minutes. For each washing water was 
filled-up to 10 ml and the solution was drained out of filter and sonicated for 20 seconds. 
The process was repeated 5 times. Glucose solution 5% (w/w) was used for the last washing 
by centrifugation (3900 RPM, 30 minutes). Finally, PEG-NPs were resuspended in 2 ml 
solution of glucose 5% (w/w). The pH of final suspension was adjusted between 7.2 and 7.5 
with a few drops of diluted NaOH. The suspension was split into 4 tubes of 0.5 ml each 
which were kept in the dark at -20oC. 
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Carboxymethyl dextran coating 
2 mL of suspension were prepared as following: 667 µL of RFe, i = 0.50 NPs in HCl 10-
2M ([Fe] = 0.12 mol/L) were diluted in 10 ml of HCl 10-2 M (pH=2) and sonicated for 30 
minutes (SA). Then 3.5 mg Carboxymethyl dextran sodium salt (CMD) (MW= 10-20 kDa) 
was dissolved in 10 ml of water (SB). SA and SB were mixed and gently shaken at room 
temperature for 2 hours. The CMD-coated NPs were collected by centrifugation (7300 
RPM, 30 minutes) and resuspended in 2 ml solution of glucose 5% (w/w). SA and SB were 
mixed and gently shaken at room temperature for 2 hours. Then, CMD-coated NPs were 
collected by centrifugation (7300 RPM, 30 minutes) and resuspended in 2 ml solution of 
glucose 5% (w/w). The pH of final suspension was adjusted between 7.2 and 7.5 with a few 
drops of diluted NaOH. The suspension was split into 4 tubes of 0.5 ml each which were 
kept in the dark at -20oC. 
Carboxymethyl pullulan coating 
50 mg of RFe, i = 0.50 NPs (average size is 4 nm), 80 mg of dimercaptosuccinic acid 
(DMSA) and 25 ml of absolute ethanol were sonicated for 30 minutes. DMSA-0.50 were 
washed 2 times with ethanol. Then DMSA-0.50 were resuspended in 8 ml of ethanol. The 
mixture of 160 mg of CMP in 16 ml of HCl 10-3 M (pH=3.5) and DMSA-0.50 in 8 ml of 
ethanol was shaken for 24 hours at room temperature for ligand exchange. CMP-0.50 were 
collected by centrifugation (8000 RPM, 15 minutes) and washed several times with pure 
water. Finally, CMP-0.50 were resuspended in 8 ml solution phosphate-buffered saline 
(PBS) and kept in the dark in a refrigerator at 6 oC. 
Note: the synthesis and the characterization of CMP are described in Appendix F. 
2.1.5. Fucoidan content 
The fucoidan coating was evaluated by the amount of sulfate groups per gram of NPs 
[35]. Sulfate content was obtained by formation of methylene blue after acidic hydrolysis of 
the samples, reduction of sulfate as hydrogen sulphide, and formation of methylene blue 
from N,N-dimethyl phenylene diamine dihydrochloride in strong acidic medium in presence 
of ferric chloride. 100 to 200 µL of the suspension of Fuco-0.50 were added to 5 mL a 
reducing mixture prepared with 100 µL of concentrated hydriodic acid, 25 µL of glacial 
acetic acid and 2.5 g of hypophosphorous acid. The mixture was refluxed for 20 min 
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through a water-cooled condenser under a stream of N2 (100 mL min-1) which carried away 
evolved hydrogen sulphide (H2S). After bubbling through a gas-washing column (20 mL of 
tris buffer 0.1 M, pH 7.2), H2S was trapped as zinc sulphide in 30 mL of a solution of zinc 
acetate prepared by diluting 5 mL of 0.50 M and sodium acetate 0.10M with 25 mL of 
deionized water. Eight mL of 16 mM ferric chloride in H2SO4 0.1 M, and 2 mL of 3.7 mM 
N,N-dimethyl phenylene diamine dihydrochloride in H2SO4 9 M were added to the zinc 
sulphide solution, and the final volume was adjusted to 50 mL with deionized water. The 
vial was maintained at room temperature under dark for 20 min and the absorption was 
measured at 665 nm with a UV-visible spectrophotometer (mc2, Safas, Monaco). The 
amount of sulphur was determined from a standard curve obtained with potassium sulfate 
solutions submitted to the overall process. 
2.1.6. Particle size analysis and isoelectric point analysis 
The hydrodynamic diameter of particles in PBS (0.5M Zn) and the zeta potentials were 
measured by dynamic light scattering (DLS), using a Zetasizer Nano S. Size (Malvern 
Instruments, UK) measurements range from 0.3 nm (diameter) to 10 microns. Zeta potential 
dependence on pH was obtained by measuring the zeta potential in aqueous solution by 
adjusting the pH value by the addition of HCl and NaOH (1 M). 
For measurements, the folded capillary cell is filled up with 1 ml of NPs in PBS (CFe ~ 
1 mM). The hydrodynamic diameter and the zeta potentials are measured at 25oC.  
2.1.7. UV-visible and fluorescence spectroscopy 
The absorption spectra were recorded by JASCO V-630 UV-visible spectrophotometer 
(JASCO, Germany). Fluorescence spectra were measured by FluoroMax Plus (HORIBA 
Scientific, Japan). 
2.1.8. FT-IR spectroscopy 
The mixture of 1 mg of NPs powder and 100 mg of potassium bromide (KBr) was 
grinded into fine powder. The powder then is left drying at 70oC overnight. Finally, the 
powder pressed by a hydraulic compressor with approximately 10-ton force made 13 mm 
pellets. All of the measurements were recorded by NICOLET 380 FT-IR (Thermofischer, 
France). 
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2.1.9. Magnetic properties 
The magnetic behavior of the as-synthesized nanoparticles was characterized at room 
temperature using a vibrating sample magnetometer, VSM (Quantum Design, USA). The 
VSM measures the magnetization by cycling the applied field from -30 kOe to +30 kOe, 
with a step rate of 100 Oe/s. 
2.1.10. Relaxivity 
The relaxation rates of NPs in suspension are obtained by linear fitting relaxation rates 
(1/T1) and (1/T2) versus different Fe concentrations. The 500 µl tubes were carefully filled 
up with colloidal NPs suspension (CFe = 0.0261, 0.0522, 0.0774, 0.113, 0.147, 0.303, and 
0.7 mM or 1.46, 2.93, 4.39, 6.32, 8.26, 17.0, and 3.92 mg Fe/L). All of the tubes were 
checked to confirm that there are no air bubbles remaining in the tubes. The relaxation times 
T1 and T2 were measured with the small animal 7T MRI Bruker Pharmascan (Bruker, 
Germany). 
2.1.11. Transmission electron microscopy 
TEM images were taken on a JEOL JEM-ARM200F Cs-corrected Field Emission 
Transmission Electron Microscope (JEOL, USA). Samples were prepared by dropping of 
the colloidal suspension onto holey carbon-coated Cu grid.  
2.1.12. X-ray diffraction 
The equipment used for these measurements is an INEL EQUINOX 1000 X-Ray 
diffractometer in asymmetric geometry (INEL, France). The X-Ray monochromatic incident 
beam (Co Kα1 = 0.1788976 nm radiation) makes an angle of around 6° with the sample. 2 
crossed slits (0.15*5mm²) are placed in trough the beam at 70mm before the sample. A 
continuous rotation of the sample (around the normal of the analysed face) is done during 
the acquisition time in order to reduce texture effects. Line profiles are collected on a curved 
linear detector (0°-115°) placed at 180mm from the sample. In order to characterize the 
different phases (lattice parameters, microstructures, % of phases …) Rietveld refinements 
were performed using MAUD software (Material Analysis Using Diffraction) [120]. 
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2.1.13. Thermogravimetric analysis 
The average number of CMD, PEG and Fucoidan molecules per nanocrystal was 
measured by thermogravimetric analysis using a LabsSys evo TG-DTA-DSC 16000 device 
(Setaram Instrumentation, France). 15 mg of coated NPs was put in a furnace tube. The 
temperature of the furnace was controlled from 30oC to 1500oC. 
2.2. Results and discussion 
We synthesized the Zn(Fe)O NPs by polyol method with Fe ratio = RFe = 0, 0.05, 0.10, 
0.15, 0.2, 0.35 and 0.50 (mol/mol). The advantages of using this method are the polar 
character and the high boiling point of the solvents, which makes it possible to solubilize a 
large number of metallic precursors and to activate efficiently the reactions [121, 122]. 
Anyway, NPs were synthesized by different ways (see Appendixes). Finally, we found that 
by using azeotropic distillation to remove water from the starting mixture, NPs were very 
small with a narrow size distribution. The Figure 2.1 presents a scheme of the system which 
was used. 
It should be noted that as much as possible, the NPs have been maintained suspended 
in a liquid phase. Very small samples were dried only to estimate yields (always above 70% 
with the azeotropic method) and to perform some analyzes (such as XRD and TGA) 
requiring dried powders. The concentration of the suspensions was determined by chemical 
analysis. There were two reasons for this strategy: NPs in the dry state are very difficult to 
resuspend in liquids and their potential toxicity to the manipulator is limited in the liquid 
phase. However, the suspensions were most often unstable and few minutes of treatment 
with ultrasounds were needed before use (with some exceptions, in particular with coated 
NPs). 
2.2.1. NPs synthesis in Propylene glycol 
Chemical analysis 
Chemical analysis was performed by atomic absorption to provide iron and zinc 
content. Measured RFe values increased with the initial amounts of salts but they were 
always lower than the starting ones. 
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Table 2.1. Chemical analysis of Fe in NPs synthesized in PG 
RFe initial 
(mol) 
RFe measured 
(mol) 
RF e= 0.05 0.498 
RFe = 0.10 0.0805 
RFe = 0.20 0.181 
RFe = 0.50 0.499 
TEM and XRD analyses 
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Figure 2.2. TEM images and size distribution of bare ZnO NPs.  
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Figure 2.3. TEM images and size distribution of bare NPs with RFe= 0.2. 
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Figure 2.4. XRD diffractogram of bare ZnO (left) and RFe= 0.2 (right) NPs. 
In Figure 2.2 and Figure 2.3, the TEM images show that the mean size of bare ZnO 
and Zn(Fe)O RFe = 0.2 is only about 7.5 nm with narrow size distribution. 
The crystalline quality and phase purities of the prepared Zn(Fe)O samples 
synthesized in PG with azeotropic distillation were examined by powder XRD method 
(Figure 2.4). The crystalline sizes of all NPs samples were calculated using the highly 
intense peak by Scherrer’s formula. It was found that all of the diffraction peaks are come 
from wurtzite ZnO phase. No other impurity peaks are detected indicating the purity of the 
synthesized samples. The calculated averaged crystalline size of NPs is around 6 nm which 
matches with results of TEM). The size of XRD are smaller than size TEM. So, there are 
amorphous layers outside the NPs. 
Magnetic properties 
The magnetic properties of the RFe= 0.5 NPs powder were determined at 5 K and 300 
K using a vibrating sample magnetometer (VSM) in the applied filed ranging from −70 to 
+70 kOe (Figure 2.5). Hysteresis plots show the variation of magnetization (M, emu/g) as a 
function of applied magnetic field (H, Oe). The weak magnetism confirms that, the NPs are 
wurtzite phase. Because of the weak magnetism, we did not consider NPs synthesized in PG 
for further works.  
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Figure 2.5. Magnetization (M) versus temperature (left) and versus applied field (H) at 5 K 
and 300 K (right) of RFe= 0.2 NPs synthesized in PG. 
 
2.2.2. NPs synthesis in diethylene glycol  
Chemical analysis 
Chemical analysis was performed by atomic absorption and UV-visible spectrometry, 
to provide iron and zinc content (Table 2.2). 
Table 2.2. Chemical analysis of Fe in NPs synthesized in DEG with RFe = 0.05, 0.1, 0.15, 
0.2, 0.35 and 0.50. 
RFe initial 
(mol) 
RFe measured 
(mol) 
RFe, i = 0.05* 0.064 
RFe, i = 0.1 0.191 
RFe, i = 0.15* 0.179 
RFe, i = 0.2 0.198 
RFe, i = 0.35* 0.461 
RFe, i = 0.50 0.569 
* obtained by visible spectroscopy (see Appendix N). 
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Measured RFe values increased with the initial amounts of salts and they were always 
higher than the initial ones. 
TEM and XRD analyses 
Bare NPs 
TEM and XRD analyses were performed and data are presented on Figure 2.6 and 
Figure 2.7. The TEM images were analysed manually using the graphical software ImageJ 
with measurement of about 200 NPs for each sample. Results are presented in Table 2.3. 
   
(a)    (b)    (c) 
Figure 2.6. TEM images of RFe, i = 0.05 (a), 0.20 (b) and 0.50 (c). 
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Figure 2.7. XRD diffractograms of RFe, i = 0.05, 0.10, 0.15, 0.35 and 0.50. 
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We use XRD to investigate phase and crystal of bare NPs with different Fe 
concentration. In the Figure 2.7, we can see that the diffractograms of the RFe, i = 0.05-0.35 
NPs are the same. All of them are belong to Wurtzite ZnO phase. This classical crystalline 
structure for ZnO is presented on Figure 2.8 . 
In the case of the sample RFe, i = 0.50, we found a new peak, which is the evidence of 
other phase. By analyzing XRD, we found the presence of a cubic spinel phase which is 
characteristic of the ZnFe2O4 crystalline structure in this sample. Analysis of XRD 
diffractograms allows the determination of cell parameters, and of the crystalline size 
through Scherrer’s formula (also called coherent domain of diffraction). The size of XRD 
are rather close to the size obatained by TEM and they are alway smaller than size TEM. 
Size of XRD is the size of cristal core, size of TEM is the real size. So, there are amorphous 
layers outside the NPs. Using stoichiometry  we can calculate ration mol/mol between to 
phase. All these data are presented in Table 2.3. 
 
                                                
(a)                                                                                    (b) 
Figure 2.8. Wurtzite structure: (a) unit cell; (b) hexagonal structure [123]. 
So, XRD evidenced a wurtzite phase of zinc oxide doped with iron ions, with Fe 
concentration up to RFe, i =0.35, and a mixture of iron-doped wurtzite ZnO phase and a 
ZnFe2O4 cubic spinel phase for RFe, i =0.50. The sizes of NPs obtained from TEM were 
ranging from about 3 nm to 7 nm, in good accordance with the coherent domains of 
diffraction obtained from XRD measurements. The sizes are much smaller than the NPs 
synthesized in previous studies by Balti et al: 17 nm [3], Dinesha et al : 19–34 nm [124], 
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Ciciliati et al : 11-25 nm [125],   Il’ves et al : 10–20 nm [126] and Arciniegas-Grijalba et al : 
20- 35 [127]. 
Without water, the particles are smaller than in presence of water. The main reason 
could be the quick formation of initial nuclei when the temperature reaches the reaction 
threshold temperature (at 200oC). Because the quantity of particles is increased, the mean 
size of resulting particles is decreased [128]. 
Table 2.3. Characterization of bare DEG-NPs. Rietveld refinements for NPs with RFe, i = 
0.50 have been performed with the stoichiometry established from chemical analysis. 
 
RFe initial Size  
TEM 
(nm) 
Size 
XRD* 
(nm) 
XRD  
Lattice parameters 
(nm) 
RFe  
 
RFe, i = 0.05 7  5.9 Wurtzite 
a: 0.325839±6.68E-5; 
c: 0.53225±2.05 E-4. 
0.064 
RFe, i = 0.1 ND 7.0    Wurtzite 
a: 0.32691±3.7 E-5; 
c: 0.52280±8.9 E-5 
0.191 
RFe, i = 0.15 6.9 6.7    Wurtzite 
a: 0.327126±4.6 E-5; 
c: 0.52281±1.156 E-4 
0.179 
RFe, i = 0.35  6.3 5.8   Wurtzite 
a: 0.327094±2.83 E-5  
c: 0.531681±2.83 E-5 
0.461 
RFe, i = 0.50  4.2  3.85  Wurtzite : Zn0.54Fe0.46O 
a: 0.32499±1.78 E-4;  
c: 0.530024±3.87 E-4 
0.72 (mol/mol), 0.45 (w/w) 
0.569 
4.07 
 
Cubic: ZnFe2O4 
a: 0.84752±4.39 E-4 
0.28 (mol/mol), 0.55(w/w) 
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Coated NPs 
We coated all of NPs with fucoidan for detection of thrombosis by MRI. CMD coating 
was performed on NPs with RFe, i = 0.50 and used as a reference for MRI experiments. The 
TEM images of fucoidan-coated NPs are shown in Figure 2.9. TEM images of fuco-0.35 (a) 
and fuco-0.50 (b). 
. 
   
(a)      (b) 
Figure 2.9. TEM images of fuco-0.35 (a) and fuco-0.50 (b). 
The TEM images did not evidence the fucoidan coating. However, the sizes of the 
inorganic cores remained below 10 nm with a narrow distribution in good agreement with 
the sizes of the corresponding bare NPs and XRD data. 
Hydrodynamic diameters, zeta-potential and stability of coated NPs in water were 
determined by dynamic laser light scattering (DLS). As we are going to see it in next 
subsections, the results of zeta potential, light scattering, IR, absorption spectra and 
thermogravimetry analysis (TGA) e the presence of fucoidan, and CMD. 
Stoichiometry 
The formation of Zn(Fe)O crystals without modification of the elementary cell, ie 
leading to the same crystal lattice is obtained either by substitution of some zinc ions by iron 
ions, or by inclusion of iron ions into tetraedic sites of the hexagonal cell [3, 124]. For RFe,i 
= 0.50, we tried to propose a steoechiometry for the hexagonal phase by making the 
hypothesis of substitution. In this case there is a simple relation between iron and zinc 
content:   Znx(Fe)yO with x+y=1 
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Let us assume that the number of mol Znx(Fe)yO and ZnFe2O4 is labelled by a and b, 
respectively. 
From XRD data, we found that the ratio between weight of Znx(Fe)yO and ZnFe2O4 is 
0.43:0.57 (table 2.2). From AAS data, the ratio between the number of mol of Zn and of Fe 
in RFe, i = 0.5 would be 0.45:0.55. 
Hence, we can evaluate x and y by solving the system of equations 2.1: 
⎩
⎨
⎧
x +  y = 1
(଺ହ୶ାହ଺୷ାଵ଺)ୟ
(଺ହାଵ଺଼ାସ଼)௕
= ଴.ସହ
଴.ହହ
୶ୟାୠ
୷ୟାଶୠ
= ଴.ସଷ
଴.ହ଻
         (2.1) 
In this system, the first equation accounts for the fact that Fe doping in ZnO takes 
place by substitutions of Zn by Fe, the second equation accounts for the 0.45:0.55 weight 
ratio between both phases, and the third equation accounts for the ratio of the number of mol 
of Zn and of Fe. Finally, we have: 
൝
a = 2.55b
x = 0.54
y = 0.46
          (2.2) 
From the calculated results, we know that the DEG-0.50 is the mixture of 
Zn0.54(Fe)0.46O and ZnFe2O4, and the ratio between number of mol Zn0.54(Fe)0.46O and 
ZnFe2O4 is 2.55:1. The ratio of Zn and Fe in Znx(Fe)yO phase is rather similar with the 
initial composition. In addition, the beginning of formation of ZnFe2O4 in this sample can 
be observed. 
 
Hydrodynamic size and stability 
The colloidal stability of fuco-NPs dispersed in physiological suspension was 
compared with that of uncoated ones. The bare DEG-NPs are stable in ethanol, but when it 
was changed to water medium, a quick aggregation is observed. After few hours, most of 
DEG-NPs were precipitated. In contrast to uncoated one, the suspension of fuco-NPs 
remained stable for more than 3 months in water or PBS solution (Figure 2.10). 
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Figure 2.10. RFe, i = 0.50 (left), fuco-0.50 (middle), and fuco-0.50 with applied magnetic 
field (right) in PBS. 
We measured the hydrodynamic diameters and the zeta-potentials of coated NPs 
dynamic laser light scattering (DLS) in water at pH ranging from 6.5 to 6.8 (table 2.4). Size 
distribution of fuco-0.50, and CMD-0.50 is presented in Figure 2.11. 
1 10 100 1000 10000
0
2
4
6
8
10
12
(a)
Fr
eq
ue
nc
y
Diameter(nm)
1 10 100 1000 10000
0
2
4
6
8
10
12
14 (b)
Fr
eq
ue
nc
y
Diameter(nm)  
Figure 2.11. Size distribution of fuco-0.50 (a), and CMD-0.50 (b). 
Polydispersity index (PDI) indicates the stability of the NPs colloidal suspension: 
PDI = 0-0.2: suspension is monodisperse, 
PDI = 0.2-1: suspension is polydisperse, 
PDI > 1: suspension is aggregated. 
The results indicate that coated NPs with RFe, i = 0.5 suspension is stable, whereas 
aggregation was observed with lower ratios. 
The table 2.3 gathers the average sizes and the zeta potentials of fucoidan-coated NPs. 
Although we focused on fuco-0.50, NPs with RFe = 0.05, 0.15 and 0.35 have been 
successfully coated with fucoidan. With the exception of fuco-0.05, all sizes were lower 
than 500 nm and negative zeta potentials evidenced the negatively charged coatings.  
 
 
Chapter 2. Chemistry 
35 
Table 2.4. Average hydrodynamic size and zeta potentials of NPs 
Coating -RFe 
Core size 
(nm) 
Size  
(nm) 
Zeta-potential 
(mV) 
PDI 
Fuco-0.05 5.9 1153 7.3 0.582 
Fuco-0.15 6.7 459 -32.4 0.425 
Fuco-0.35 5.8 362 -36.8 0.463 
Fuco-0.50 4.2-7.4 162 -48.7 0.135 
CMD-0.50 4.2-7.4 177 -33.3 0.150 
 
Magnetic properties 
The magnetic properties of RFe, i = 0.50 (powder) were determined at 5K and 300K 
using a vibrating sample magnetometer (VSM) when the applied field ranged from −70 to 
+70 kOe (Figure 2.12b). Hysteresis plots show the variation of magnetization (M, emu/g) as 
a function of applied magnetic field (H, Oe). We determined also the magnetic properties of 
the coated NPs at 300 K when the applied field ranged from −30 to +30 kOe (Figure 2.12c). 
It is clear from Figure 2.12b that RFe, i = 0.50 is superparamagnetic with saturation 
magnetizations of 53 emu/g and 27 emu/g at 5K and 300K, respectively. With RFe, i  = 0.50, 
crystal phase of NPs is a mixture of ZnFe2O4 and Wurtzite (Wurtzite: 0.45; ZnFe204: 
0.55(w/w)), which is superparamagnetic with a very small hysteresis loop at room 
temperature [129, 130]. Fuco-0.05, fuco-0.15 and fuco-0.35 are paramagnetic (see 
Appendix H) whereas fuco-0.50 is superparamagnetic as expected since the coating did not 
modify the structure of the inorganic core. The saturation magnetizations of RFe, i = 0.50, 
fuco-0.50 and CMD-0.50 were approximately 22-25 emu/gram (Figure 2.12c). 
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Figure 2.12. Magnetization (M) versus temperature (a), versus applied field (H) at 5 K 
and 300 K (b) of RFe, i = 0.50, and versus applied field (H) of RFe, i = 0.50, fuco-0.50 and 
CMD-0.50 in water (c, d). 
Absorbance and fluorescence spectra 
The absorption spectra of RFe, i = 0.50, fuco-0.50 and CMD-0.50 are presented in the 
Figure 2.13. The absorption wavelength of NPs was observed in UV band. 
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Figure 2.13. Absorption spectra (left) and fluorescence spectra (right) of RFe, i = 0.50, 
fuco-0.50, and CMD-0.50 with 370 nm excitation wavelength. 
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We looked at the photoluminescent properties of coated NPs in water. The 
photoluminescent spectra with an excitation at 370 nm indicated that the RFe, i = 0.50 have a 
broad visible band with a maximum intensity of photoluminescence at 470 nm due to 
various intrinsic defects in oxides such as oxygen vacancies, interstitial zinc, singly ionized 
oxygen vacancies, antisite oxygen, zinc vacancies and even oxygen surface defects [131, 
132, 133]. 
Infrared absorption spectroscopy 
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Figure 2.14. IR absorption spectra of RFe, i = 0.50 (a), fuco-0.50 (b), and CMD-0.50 (c). 
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We compared infrared (IR) absorption spectra of uncoated RFe, i = 0.50 with those of 
coated NPs. The surface coatings can be evidenced (Figure 2.14). 
We can clearly see the difference of the infrared absorption spectra peaks between 
uncoated NPs and coated NPs. In addition, the peaks of infrared absorption spectra between 
the coated NPs and the surface coatings material completely matched. The results evidenced 
fucoidan, and CMD in the studied samples. 
Thermogravimetry analysis 
Thermogravimetry analysis (TGA) is a method of thermal analysis that can give 
information about amount of water and organic layer in the decomposition of coated NPs by 
tracking the weight loss versus time and temperature. In this measurement, 15 mg of coated 
NPs were put in a furnace tube. The temperature of the furnace was controlled from 30 oC to 
1500 oC. 
 
 
Figure 2.15. Thermogram of fuco-0.50 and CMD-0.50. 
The thermogram is presented on Figure 2.15, where the sample mass is plotted (green 
curve) together with its derivative (mass loss versus temperature, violet curve).  In this 
dTG 
TG 
dTG 
TG 
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figure, the first slope is the loss of free water which was complete around 200°C. The 
second slope is the carbonization of the cover materials and this process takes place between 
200 °C and 600 °C. The last slop corresponds to the remaining oxide NPs that lost very little 
mass between 600 °C and 1500 °C. By calculating the mass loss of the sample, the weight 
ratio of cover material to the metal oxide core could be estimated.  
By analyzing the thermogram, we estimated that fuco-0.50, and CMD-0.50 contained 
37.4%, and 48.4% of polymer, respectively. From ratio of weight between the coating 
material and the core, average number of fucoidan molecule per NP was estimated 57 and 
average number of CMD molecule per NP was 22-44. 
Fucoidan content 
The fucoidan content (mol/w) in fuco-0.50 sample was determined by a colorimetric 
method currently used in the LVTS [35]. From this result, we have estimated the average 
amount of fucoidan molecule per nanoparticle by considering the following data: 
- XRD data have established that fuco-0.50 is a mixture of 0.45/0.55 (w/w) of 
wurtzite/ spinel cubic nanocrystals with the average diameter of NPs in both phases is 
approximately 4.0 nm. 
- All calculations were performed by considering an average density of NPs of 5.0 
g/cm3, corresponding to ZnO-based nanoparticulate systems described in the literature [35]. 
- Whatever the diameter of the NPs, fucoidan molecules likely interact with their 
surface in a similar way. 
Thus we established that 0.5 mg of NPs was corresponding to 2.5x1015 NPs, with 
surfaces of 1400 cm2. Knowing that the sulfate content and the molecular weight of 
fucoidan were 26.5 g/100g and 10,100 g/mol respectively, a suspension of 17.36 mg of 
fuco-0.5/mL would correspond to 47 nmol of fuoidan/mg. Eventually, the average number 
of fucoidan molecule per NP was estimated 30. This result is good agreement to our results 
from TGA. 
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Relaxivity 
Relaxivity is an importance parameter of a MRI contrast agent. The relaxivity of 
coated NPs in water was measured by MRI. 
We prepare a lot of tubes with different Fe concentration. In MRI image, the contrast 
agent will have darkening effect. The higher concentration the darker image.  
Figure 2.16 shows MRI image of tubes with different Fe concentration. Tube lettered 
with A is the most concentrated of Fe, and G is the most diluted Fe concentration. 
Relaxation times T1 and T2 of samples were obtained by fitting average intensity of sample 
versus time with exponential function. 
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Figure 2.16. MRI image (left) and relaxivity determination of Fucoidan-NPs suspension 
(RFe=0.5) with (CFe = 0.7(A), 0.303(B), 0.147(C), 0.113(D), 0.0774(E), 0.0522(F), and 
0.0261(G) mM. 
The relaxation rates of NPs in suspension were obtained by linear fitting relaxation 
rates (1/T1) and (1/T2) versus different Fe concentrations. The slopes of the lines 
present r1 and r2. 
Contrast agents can be divided into two categories, based on the r2/r1 ratio. The low r2/r1 
ratios (close to 1) are referred to as T1 contrast agents. On the other hand, with r2/r1 ratios 
superior to 5 are called T2 contrast agents [134, 135]. The r2/r1 ratios of NPs (RFe = 0.05, 
0.15, 0.35 and 0.50) are from 3.9 to 6.9 (>>1), the value indicates that the NPs had the 
potential as effective T2 contrast agents.  
We selected the NPs with RFe = 0.50 for MRI because of the high r2 value. It can be 
found in the literature that the value of r2 does not only depend on maximum magnetization 
but also depends on coating agents, particle size and shape [136].The values of r2 and r2/r1 
ratio can be controlled by modulating the size [134]. Table 2.5 shows results of relaxivity of 
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our NPs compare to the other publications. Relaxivity is depended on coating agents, 
particle size and shape. With the same size of NPs, our NPs have better r2 value than the 
other. 
Table 2.5. Characterization of coated NPs compared to references  
magnetic 
core 
TEM 
core size 
(nm) 
coating  r1 
(mM-1s-1) 
r2 
(mM-1s-1) 
r2/r1 B0  
(T) 
refs 
Zn(Fe)O + 
ZnFe2O4 , 
RFe=0.5 
4.3 fucoidan 25.0 173.5 6.9 7 this 
works 
Zn(Fe)O + 
ZnFe2O4, 
RFe=0.5 
 CM dextran 43 295 6.8 7 this 
works 
iron oxide 4.5 dextran 10.1 120 11.9 1.5 [137] 
iron oxide 3 −5 dextran 7.3 57.0 7.8 1.5 [138] 
iron oxide 4.5 dextran + 
citrate 
5.0 66.0 13.2 1.4  [139] 
γ-Fe2O3 3 PEG-
phosphine 
oxide 
4.8 29.2 6.1 3 [140] 
γ-Fe2O3 4.8 uncoated 3.52 28.3 5.9  [141] 
Fe3O4 4 PEG-
phosphine 
oxide 
5.9 39 6.6 1.4 [142] 
Fe3O4  2.2   6.15 28.62 4.65  [143] 
ZnFe2O4  4.8 chitosan   68  9.4 [144] 
ZnFe2O4  4.8 PEG  76   9.4 [144] 
ZnFe2O4  6.1 hydrophilic 
polyol 
ligands 
6.84 15.77 2.31 1.41  [145] 
ZnFe2O4 5.9 PEG 0.60 49 82 9.4 [146] 
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2.2.3. Conclusion 
Water removal using Dean-Stark apparatus is a novel strategy for the synthesis of NPs 
in polyol solution with high yield and small size. Using PG as solvent, we obtained NPs 
with high yield, and small size, but the magnetic properties of those NPs were very weak, 
and they were not suitable for MRI. 
Using DEG as solvent, the transition from wurtzite ZnO phase to ZnFe2O4 spinel phase 
could be seen when we increase the Fe concentration up to 0.5, shown by a 
superparamagnetic behaviour at room temperature. However, because of a high 
homogeneity of nanocrystal size, the phase mixture could only be demonstrated by XRD 
analysis. The fucoidan and CMD coatings were confirmed by DLS, FT-IR spectra, and 
TGA results. Fucoidan-coated and CMD-coated NPs with RFe, i = 0.5 were used for animal 
experiments as described in chapter 4.  
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Chapter 3. Optics 
In optical imaging, the microscope is one of the most important equipment. We can 
improve both the contrast of images and the ability to detect NPs by the use of additional 
components.   
3.1. Development of the optical system 
Image data was collected with a Zeiss inverted microscope (Axio Observer A1m) 
equipped with an Andor EMCCD camera (Andor iXon 897) cooled at -70°C. We modified 
the microscopy setup using some external optical elements in different configurations for 
imaging atherothrombosis. 
3.1.1. Fluorescence microscopy 
Experimental setup 
 
Figure 3.1. Fluorescence microscopy configuration. 
This is the basic setup (Figure 3.1). A 20 mW UV diode laser (Laser Stradus, Vortran 
Medical Technology) is the light source. A filter cuts off the unwanted photons from the 
laser source: the laser indeed has some internal parasitic fluorescence, which could be seen 
on the fluorescence spectrum. An aluminium mirror directs the laser beam towards the 
sample. Another filter stops the laser beam from hitting the CCD camera. A microscope 
collects fluorescence signal from the sample.  
Laser 370 nm 
20 mW 
Mirror 
µObj. 
 
CCD 
Camera 
Slice 
Excitation filter 
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3.1.2. Simple dark field microscopy 
Experimental setup 
Because dark field microscopy can provide very high contrast images, we developed a 
dark field microscope to detect our NPs by scattering. If successful, this microscope can be 
used in order to image atherothrombosis. Dark field microscopy configuration is shown in 
Figure 3.2. 
 
Figure 3.2. Dark field microscopy configuration. 
A 14 mW polarized Helium-Neon laser (Melles Griot) is the source light. Here we 
don’t use polarization for our measurements. However, we are sure that random rotation of 
the polarization inside the laser doesn’t induce fluctuations in the intensities. An aluminium 
mirror direct the focused laser beam to the sample contained in a capped cuvette or between 
two glass slides. By using lenses, laser beam size is adjusted to about 100 µm. Again, 
scattered light from the sample is collected by the microscope.  
 
3.1.3.  Dark field interference microscopy 
Experimental setup 
This is an evolution of the previous basic dark field microscope (see Figure 3.3). Now 
the microscope is part of an interferometer. We use the same 14 mW Helium-Neon laser as 
source light. The laser beam is split by 5:95 beam splitter. The strong beam (95% of energy) 
is focused on the sample. By using lenses, laser beam size is about 100 µm diameter at the 
Laser 633 nm 
15 mW 
Mirror 
µObj. 
 
CCD 
Camera 
 
Slice 
Lens 
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sample. The remained beam (5% of energy) passes thought a 10X beam expander. It is the 
reference beam of the interferometer. The interference images between dark field image and 
reference beam are recorded by the EMCCD camera (see Figure 3.4). A microscope is used 
for collecting scattering light from NPs. 
 
Figure 3.3. Dark field interference microscopy configuration. 
 
Because this microscopy is based on interference, there are some advantages and 
disadvantages of this microscopy technique. 
+ Advantages: 
- High contrast, low cost. 
- Easy and accurate determination of the depth position within a large depth range with 
the possibility to track many NP at the same time. 
- It should be possible to extract the interference signal of NPs from strong background 
noises by using a high pass frequency filter. 
+ Disadvantages: 
- Difficult to align the beam properly. 
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- Sensitive to vibrations due to human activities, building vibration, acoustic noise. 
 
(a) 
 
(b) 
 
(c) 
Figure 3.4. Dark field image of NP (a), reference laser beam (b) and interference image (c). 
3.1.4. Dark field hyperspectral microscopy 
Hyperspectral imaging has been used in numerous applications in diverse fields such 
as agriculture, chemical imaging, food processing, environment and military. More recently, 
hyperspectral imaging microscopy plays an important role in biological imaging 
applications, where it has found utility to precisely identify and quantify 10 molecular 
markers in individual cancer cells in a single pass [147]. It can also be used for 
nanoparticles mapping [148, 149].  
Experiment setup 
 
Figure 3.5. Hyperspectral dark field microscope configuration. 
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Chapter 3. Optics 
47 
We built our own system based on our microscope (see Figure 3.5). The source is a 50 
Watt halogen lamp. By using lenses and mirrors, the light beam passes thought a 1 nm 
resolution monochromator. The selected light is focused into the sample. The EMCCD 
camera shoots images through the microscope. All measurements are taken at room 
temperature (20oC). A motor attached to the spectrometer tunes the wavelength. At each 
step, a 14 bits image of the sample is recorded. The full set of images, from 400 nm to 900 
nm, is analysed by a homemade software, written in the Matlab language using the Spectral 
Angle Mapper algorithm (SAM). 
3.2. Use of NPs with optical system 
3.2.1. Dark field microscopy for real-time 2D NPs tracking 
Image processing 
 
Figure 3.6. The flow charts for estimating particle size distribution. 
 
Nanoparticle tracking analysis (NTA) allows us to determine the size distribution 
profile of a group of nanoparticles in liquid suspension whose sizes range from tens to 
thousands nanometers. This technique uses an intense laser beam to illuminate freely 
moving particles dispersed in the liquid medium. It tracks their Brownian motion by 
analysis sequential images, and it estimates their size distribution using the Stokes–Einstein 
Load Image from CCD 
Background subtract, Gaussian filtering 
Peak location, Gaussian fitting-center of mass 
NPs Tracking 
Diffusion coefficient estimation 
Sizes statistic, kernel density estimation 
Chapter 3. Optics 
48 
relation. Speed of motion not only depends on the viscosity but also on the temperature of 
the fluid. It is not affected by particles density or their refractive index. NTA allows 
determining size distribution of small particles with a diameter of about 10-1000 
nanometers (nm) in liquid [150]. This technique can be used for tracking motion of 
individual NPs inside the living cell. 
A stack of images of NPs moving in suspension is recorded by the camera. Each 
individual image undergoes background subtraction and noise filtering. Then the position of 
the nanoparticles is determined by finding the local maximum intensities. Each center is 
positioned with subpixel accurately (<1 pixel) by using a 2-dimensional Gaussian fitting 
method or center of mass estimator. Once the NPs are being tracked, the diffusion 
coefficient and size of NPs can be estimated in real time. 
Background subtraction 
A background image is calculated from a large set of recorded images. If the laser 
power is stable, and if all optical elements are well fixed, every pixel of background image 
should be the minimum value at the same position within all the current data set. 
Image filtering 
Noise is an unavoidable phenomenon during any measurement. A low-pass filter is 
often used before using peaks detection algorithm because the detection algorithm is very 
sensitive to random noise (Figure 3.7). With the use of a Gaussian filter, we can improve the 
results of the peak detection algorithm. Mathematically, applying a Gaussian filter to an 
image is convolving the image with a Gaussian function. It is a frequently used as a low 
pass filter. 
  
Figure 3.7. Image of single a single NP before (left) and after applying a Gaussian filter 
(right).  
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Peaks detection and subpixel resolution 
After applying the gaussian filter, in order to remove noise, each pixel of the image 
whose intensity is higher than a given threshold value compared with at least 16 
neighborhood pixels is marked as the local maximum. That is, it is selected if intensity of 
neighboring pixels decrease in 8 directions. This is described in the Figure 3.8. The number 
of neighbors should be high enough to avoid false detection of a maximum due to the 
relatively big diffraction rings around strongly scattering nanoparticles. Position of the 
maximum pixel is said to be the initial position of the NP. 
If two or more maximum pixels are too close, that is if the distance between them is 
closer than a given value (normally comparable to the spatial resolution of the microscope), 
the pixel which has the biggest value will be kept as the “true” maximum. The other will be 
discarded as a false positive.   
 
 
Figure 3.8. Peaks detection algorithm, a pixel is determined as a peak if it is stronger than 
at least 16 nearby pixel in 8 different directions. 
 
We can find many algorithms designed to improve accuracy when determining the 
center of the NPs. Gaussian function fit and center of mass are used because these methods 
are simple while providing a high accuracy. 
For each NPs found by its maximum, the software crops the full picture into smaller 
pictures, called a ROI images (Region Of Interest). Those images contain all of an 
individual particle signal. We process these ROI in order to find precisely the location of the 
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particle with sub pixel accuracy. The accuracy of the two methods is described and 
compared in 0.  
Gaussian fit with least squares method 
Least squares method is a favourite method for locating particles with subpixel 
resolution because it is the most reliable one. Data from the ROI images are fitted with a 
two-dimensional Gaussian function by the least squares method (Figure 3.9). The results 
will determine the center position of the Gaussian with sub pixel resolution. The accuracy of 
this method depends on the scattering intensity of the particles. The resolution d is 
calculated as equation 3.1 [151]: 
𝑑 = ଵ
√ே
× ఒ
ே஺
             (3.1) 
Where N is the number of photons collected from a particle, λ is the wavelength of 
light and NA is the numerical aperture of objective lens microscope. 
Typically, image of particles on the sensor should be spread over 9 pixels to ensure 
resulting matches in the most accurate way. 
                             
Figure 3.9. ROI Image (left) 2D Gaussian function is applied to locate center more precisely 
(right). 
Center of mass method 
Center of mass is a simple method to calculate subpixel position. For each dimension, 
the center is given by equation 3.2:  
𝐶௫ =
∑ ∑ ൫௫೔×ூ೔ೕ൯ೕ೔
∑ ∑ ூ೔ೕೕ೔
            (3.2) 
where:  xi is the position in that dimension 
Iij is the intensity of a given pixel 
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Even if this method is extremely simple, its calculated results are rather good. So this 
method is a favourite when one has to deal with a very big data set with a limited computing 
power.  
 
Diffusion coefficient and size estimation 
In order to process NPs tracking, we first have to determine a region of interest where 
the particle movement will be analysed. Knowing particles minimum size in the sample, the 
temperature and the viscosity, the maximum-expected diffusion coefficient Dmax can be 
calculated by the Stokes–Einstein relation equation 3.3.  
𝐷௠௔௫ =
௞ಳ்
ଷగఎௗ೘೔೙
          (3.3) 
where:  kB is the Boltzmann constant, 
T the absolute temperature, 
η the viscosity of the medium and d the diameter. 
We can therefore introduce a radius R for this region of interest: if we choose for 
instance 𝑅 = 3ඥ𝜋𝐷௠௔௫∆𝑡, more than 99% of the expected particle steps are shorter than 
this radius [152]. Then, according to the same Stokes–Einstein relation, the diffusion 
coefficient for a spherical particle is expressed as: 
𝐷 = ௞ಳ்
ଷగఎௗ
           (3.4) 
For n dimensions the time dependence of mean square displacements for isotropic 
diffusion are: 
〈(∆𝑟)ଶ〉 = 2 × 𝑛 × 𝐷 × ∆𝑡        (3.5) 
where 〈(∆𝑟)ଶ〉 is the mean squared displacements corresponding to the time interval 
∆t. The diffusion coefficient can therefore be obtained by calculating squared displacements 
of each nanoparticle in the sequence of images. We used the ‘‘regression method’’ in order 
to calculate the estimated size of nanoparticles. The regression method is the most often 
used method in the literature to estimate the diffusion coefficient because it is simple and 
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fast. Squared displacements can be plotted versus the time intervals. The diffusion 
coefficient is estimated by the slope of the regression line fitting. 
Results and discussion 
We have synthesized RFe, i = 0.20 NPs by polyol method. These NPs were suspended 
in DEG in order to slow down their movements. We chose the concentration to be 2×107 
particles/ml of NPs. We tracked the Brownian motion of uncoated NPs in DEG cuvette 
(Figure 3.10), and the estimation of the diffusion coefficient is presented in Figure 3.11. 
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Figure 3.10. Brownian motion of NPs in DEG. 
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Figure 3.11. Estimation of the diffusion coefficient. 
Because the Rayleigh scattering decreases as the sixth power of diameter, NPs with 
very small size are very difficult to observe. As long as light scattering signals from NPs is 
higher than the noise of the medium, we can track the NPs and estimate their sizes. In our 
experiments, by isolating strong light scattering originating from the glass wall, the NPs 
with hydrodynamic diameter close to 30 nm can be tracked by our dark field microscope 
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(Figure 3.12). The limit of this method depends on the signal to noise ratio thus is given 
mostly by the combination of the laser intensity and the sensitivity of the detector. 
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Figure 3.12. Hydrodynamic size of RFe, i = 0.2 NPs measured by NTA. 
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Figure 3.13. TEM image and size distribution of RFe, i = 0.2 NPs. 
Hydrodynamic size is much greater than result by TEM but it is an expected value. 
The hydrodynamic size always bigger than the size by TEM. Because there are electric 
dipole layers outside the NPs. 
We now compare the results we obtained with NTA and DLS on CMP-NPs in water. 
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Figure 3.14. Hydrodynamic size of CMP-NPs measured by NTA and DLS. 
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Hydrodynamic size of NPs measured by NTA is in good agreement with the size given 
by the DLS method (see Figure 3.14). Nanoparticle tracking analysis is therefore a valuable 
tool for characterizing nanoparticle suspensions. In our setup, we found that this technique 
could be used for analyzing NPs as small as 30 nm. A homemade program for tracking and 
analyzing sizes in real time has been developed. 
3.2.2. Dark field interference microscopy for 3D NPs tracking 
We tried to develop three-dimensional (3D) single-particle tracking methods which 
could provide fully resolved movement of NPs in their medium. Some of them are based on 
multifocal scanning [153, 154], calculation of radial symmetry centers [155, 156]. All of 
them have some limited range along the z axis (<5 µm) because of the expanding Point 
Spread Function (PSF).  
Some kind of hologram microscopes have been developed in order to achieve high 
resolution (3 × 3 × 10nm) and a better range on the z axis (up to 30 µm) [157]. 
Herein, we present a dark field interference microscope we developed, which can track 
NPs with high resolution and range of z axis is up to 100 µm. The algorithm we wrote is 
able to locate NPs in 3D with a single image.  
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Image processing 
 
Figure 3.15. Flow-charts for 3d NPs tracking analysis. 
 
We record with the EMCCD camera images of NPs moving in suspension. As 
previously explained, each image is then background subtracted. Then the positions of the 
nanoparticles are determined following the flow chart (Figure 3.15). With a sequence of 
positions data, the diffusion coefficient and sizes of the particles are then estimated. 
  
Load Image 
Background subtract 
Convolution image with spherical wave at difference distance 
 from the observation plane 
Find z position by the best contrast determination   
Find x, y position 
Track NP and size estimation 
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Background subtraction 
The background can be determined as the image of the reference beam. The result of 
background subtraction is shown in Figure 3.16.   
  
Figure 3.16. Dark field interference image before (left) and after (right) background 
subtraction. 
Image convolution 
From the interference image, the 3D location of NPs can be calculated by the 
following steps: 
Step 1: Simulate the complex spherical wave at distance z from the observation plane.  
𝛹(𝑧) = ௘
೔ೖೝ
௥
          (3.6) 
where:  𝑟 = ඥ(𝑥 − 𝑥଴)ଶ + (𝑦 − 𝑦଴)ଶ+(𝑧 − 𝑧଴)ଶ, 
  𝑘 = ଶగ
ఒ
 is the wavenumber. 
Step 2: Compute 2-D fast Fourier transform (fft2) of spherical wave Ψ and Image IM 
recorded by EMCCD 
TFΨ = fft2 (Ψ)          (3.7) 
TFIM=fft2 (IM)           (3.8) 
Step 3: Convolve image with different planes at different distances from the objective 
focal plane (z) 
Co(z) = ifft2(TFIM.* TFΨ(z))        (3.9) 
The intensity (I) of convolution image is calculated as follows: 
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I (z)=Co(z).*conj(Co(z))        (3.10) 
Step 4: By scanning z value of the complex spherical wave, the position z of NPs is the 
value that gives the best contrast on the convolution image. The contrast of image is 
calculated as following: 
Contrast = ூ೘ೌೣିூ೘೔೙
ூೌೡ೒
         (3.11) 
Where:  Imax is the maximum value of image 
Imin is the minimum value of image 
Iavg is the average value of image 
The accuracy of 3D location algorithm is described in Appendix L. 
Results and discussion 
Vertical limit 
In order to find the vertical limit of interference microscopy, the NPs were fixed on the 
glass slide. The maximum for the depth z is determined by the longest distance from focus 
plane to NPs which can be observed by the EMCCD. Figure 3.17 shows a NP at different 
distances from the focus plane, which gradually increase from the left to the right of the 
image. 
 
(a) (b) (c) (d) 
Figure 3.17. Interference images of NP as a function of z: 0 µm (a), 20 µm (b), 40µm (c), 
and 100 µm (d). 
From an interference image, the position of a NP can be estimated by using the image 
correction algorithm. For instance the reconstruction, with different values of z, of images 
from data of Figure 3.17d is described in Figure 3.18. 
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(a) (b) (c) (d) 
Figure 3.18. Original interference image (a) and its reconstruction images at different 
depths z: 70 µm (b), 80 µm (c), and 95µm (d). 
After calculating a suitable value for z by determining the best contrast of the test 
images, the location x and y of NP can be calculated by the 2D Gaussian fitting method or 
the center of mass method. 
Figure 3.19 shows contrast of reconstructed images as a function of z. The further the 
distance, the lower contrast we have on the interference rings. In this experiment, the results 
show that the longest distance from focus plane to the NPs we can track at this time is about 
100 µm. Farther than that, the interference rings are not strong enough for reconstruction.  
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Figure 3.19. Contrast of reconstruct image versus z. 
Figure 3.20 shows the use of a Gaussian fitting for better location. FWHM of the peak 
indicates that the resolution of Z-axis is approximately 5 µm. 
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Figure 3.20. Gaussian fitting for precise determination. 
Experimentations on moving NPs 
In this experiment, we use the center of mass algorithm in order to determine the 
center of the NPs with subpixel resolution. These center give the speed with a high 
accuracy. 
   
z=0.6 µm    z=1.8 µm    z=3 µm 
   
z=4.2µm    z=5.4 µm    z=6.6 µm 
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z=7.8 µm    z=9.0µm    z=10.2 µm 
   
z=11.4µm    z=12.6 µm    z=13.8 µm 
Figure 3.21. Reconstruction image versus z. 
The interference images of moving uncoated NPs are convoluted with spherical wave 
with different depths z to get convolution images. From convolution images, the best value 
of z can be obtained from the image with the strongest contrast, where the NP’s rings are 
converted into a single point, allowing 2D Gaussian fitting for super x, y resolution. Figure 
3.21 shows convolution images of NPs in water with different z values. Using interference 
microscopy, the Brownian movement of NPs can be located in 3D.  
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Figure 3.22. Brownian movement of NP in medium. 
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Figure 3.23. The diffusion coefficient estimation. 
Brownian movement of NP in medium and the diffusion coefficient estimation are 
shown in Figure 3.22 and Figure 3.23. According to the Stokes-Einstein equation for the 
diffusion coefficient, the diameter of these NPs is about 22 nm. We have shown a dark field 
interference microscope is a useful tool for characterizing and tracking nanoparticle in 
suspensions. The technique can be used for tracking NPs as small as 20 nm in solution. For 
further studies, we expect that the nanoparticles, attached on with drugs or a biological 
label, which move in animal tissue, could be seen and could be tracked with our dark field 
interference microscope.  
  
Chapter 3. Optics 
62 
 
3.2.3. Dark field hyperspectral microscopy for locating NPs 
Image processing 
The most common algorithm used in hyperspectral imaging is the spectral angle 
mapper (SAM). SAM attempts to obtain the angles formed between the reference spectrum 
and the image spectrum, treating them as vectors in a space with dimensionality equal to the 
number of bands [158].  
The angle  between spectrum of each pixel in raw image and reference spectra is 
calculated by the equation 3.12: 
𝛼 = cosିଵ ൥ ∑ ௧೔
೙್
೔సభ ௥೔
ට൫∑ ௧೔మ೙್೔సభ ൯ට൫∑ ௥೔మ
೙್
೔సభ ൯
൩        (3.12) 
where  nb:  number of bands in the image. 
   r: reference spectrum  
   t: spectrum of each pixel 
This angle is a convenient way to express similarity or difference between optical 
spectra as a scalar value. In signal processing terms, it can be seen as a signal recognition 
process with a kind of fuzzy logic. 
Results 
We construct a synthetic image of the sample based on the spectral angle between each 
pixel spectrum and the reference spectrum, the latter being recorded on a known NP in the 
sample. The improvement of contrast can be seen clearly when comparing images obtained 
by dark field hyperspectral microscopy and conventional dark field microscopy.  
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Figure 3.24. Refection spectra of four materials present in a slice. 
The intensity in the image obtained by dark field hyperspectral microscopy indicates 
the angle between the spectrum of that pixel and the reference spectrum. A bright pixel gets 
a small angle, corresponding to a good similarity to the reference spectrum, whereas a dark 
pixel has a large angle.  
         
Figure 3.25. Image of histological sample exposed to nanoparticles obtained by 
conventional dark field (left) microscopy and dark field hyperspectral (right) microscopy. 
In Figure 3.25, the image obtained by our dark field hyperspectral microscope 
indicates that the NPs are covering the surface of the histological sample. Some dark point 
bound to the histological sample comes from some unknown contamination. All these 
details are very difficult to observe by conventional dark field microscopy. We can 
distinguish different kinds of NPs, or some kinds of their properties, by selecting those 
possessing a suitable angle  (Figure 3.26).  
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Figure 3.26. NPs in histological slices can be located by using suitable angle . 
                  
Figure 3.27. Image of NPs obtained via conventional dark field (left) microscopy and dark 
field hyperspectral (right) microscopy. 
In Figure 3.27, the results show the improvement we can get for the image's contrast 
from a dark field hyperspectral microscope. This image obtained via dark field 
hyperspectral microscopy shows that this technique can detect the small NPs that cannot be 
detected by a conventional dark field microscope. With dark field hyperspectral microscopy, 
a single nanoparticle can be detected in a complex environment.  
3.1. Conclusion 
The combination of hyperspectral imaging and dark field microscopy made a new 
powerful tool, providing images with better contrast and higher signal-to-noise ratio than 
images obtained by conventional dark field microscopy. This combination can be used for 
locating NPs, tracking NPs, size estimation of NPs in liquid medium and histological 
tissues. 
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Chapter 4. Imaging 
In this chapter we present imaging experiments with NPs we have prepared in chapter 
two. NPs have been injected in a rat model of atherothrombosis formerly used in the 
laboratory [159, 160, 34]. The model is described in the experimental part below. We used 
fuco-0.5, CMD-0.5 and PEG-coated NPs-0.5 (namely PEG-0.5, see Appendix D). MRI 
allowed the localization of the diseased areas which were harvested after the sacrifice of the 
animals and histological sections were prepared for further optical imaging. 
4.1. MRI 
4.1.1. Materials and methods 
Animal model 
A total of 12 male 7-week-old Wistar rats from CERJ (Le Genest, France) were 
prepared. To localize the treated segment during the MRI session, the distances between the 
upper and lower points of the perfused segment and the origin of the left renal artery were 
measured with the microscope eyepiece, and surgical wounds were closed. This model is 
characterized by the presence of an intra-luminal thrombus 1-3 weeks after aneurysm 
induction. In order to increase the size and the activity of the aneurysmal thrombus, 
injections of Porphyromonas gingivalis have been performed at day 8 and day 16. 
MRI session  
Rats were anesthetized with isofluorane before injection of the NPs in the vein of the 
penis. They were scanned with a 7 T small animal MRI (Bruker, Germany) before and after 
injection using a dedicated coil. 
For black-blood high resolution imaging of the aortic vessel wall, a T2 sequence with 
cardiac gating was used with the following parameter: minimum TR = 600 ms, TE = 8 ms, 
FOV= 5 cm and a matrix size of 256 x 256. Continuous slices (slice thickness = 1 mm) were 
made under the renal aorta bifurcation. Image analysis was performed using OsiriX software 
(DICOM reader v3.7). Maximum luminal narrowing was quantified by the percentage 
reduction (ΔR%) of aortic luminal area as previously published [69]. Arterial wall contrast 
agent uptake analysis was performed on slices that corresponded to histological sections. 
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Intraluminal areas that evidenced visual intraluminal hypersignal from 30 min to 1 hour 
after injection of contrast agent were manually contoured for quantitative signal analysis. 
Regions of interest were pasted on all corresponding MR images. The signal-to-noise ratio 
(SNR) of aortic wall thrombus was measured by calculating the average signal intensity in 
the region of interest from MR images at each imaging point (SNR = [SIaortic wall - 
SImuscle]/ SDnoise signal). Normalized signal enhancement (ΔNSE% = (SNRt - 
SNRbefore)/SNRbefore × 100) was calculated at 10, 30, 50, 75, 100 and 125 min after 
injection and analyses were performed between each scan time. At the end of the session, 
animals were sacrificed and the perfused portion of the aorta, including the dilatation, was 
harvested and flushed with PBS. Then the aorta was cut transversally into 2-mm width 
tissue rings which were frozen at -20°C in cold isopentane. Healthy artery parts were used 
as standard samples. 
PERLs staining 
Perls’ iron staining was performed by incubating some histological sections (two of 
them) in a mixture containing equal ratio of 2% hydrochloric acid and 2% potassium 
ferrocyanide for 20 min, followed by counterstaining with nuclear fast red. Deposits of iron 
were stained as blue by Perl’s Prussian blue staining, while cytoplasm and cellular nucleus 
were stained as pink and red, respectively. 
4.1.2. Results and discussion 
In vivo MR imaging experiments were performed with fuco-0.50, CMD-0.50 and 
PEG-0.50, the two latter being considered as reference compounds devoid of biospecificity. 
The difference of MRI images between before and after injection with fuco-NPs was clear, 
appearing as a contrasted black area (see red circle on Figure 4.1). Fuco-NPs were likely 
linked to the thrombus through an interaction with P-selectin overexpressed by aggregated 
platelets [161]. As expected, CMD-NPs did not induce a contrast enhancement (figure 4.2). 
To confirm the active targeting of fuco-NPs, the third rat was injected with a same amount 
of CMD-NPs and fuco-NPs. In the first step, the rat was injected CMD-NPs. Two hours 
after CMD-coated NPs injection, the atherothrombosis area was not darkened on MR 
images. In the next step, fuco-NPs were injected into the rat. In MR images, 
atherothrombosis can be detected as dark areas because of the interaction between fucoidan 
and P-selectin. Figure 4.3 shows the mean value of MR signal on the diseased area (red 
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circle on figure 4.1 and 4.2), versus time after CMD-coated NPs and fucoidan-coated-NPs 
injection. The MR signal was nearly constant after CMD-coated NPs injection but it 
decreased fast after fucoidan-coated-NPs injection.  
 
   
0 min 18 min 54 min 
   
78 min 103 min 128 min 
Figure 4.1. MRI of atherothrombosis after fuco-NPs injection. 
 
    
         Before injection     after CMD-NPs injection   after fucoidan-NPs injection 
Figure 4.2. MRI of atherothrombosis after CMD-coated NPs and fucoidan-coated NPs 
injection. 
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Figure 4.3. MR signal versus time after CMD-coated and fucoidan-coated NPs injection 
on T2* weighted MRI images. 
PEG-coated NPs did not bear fucoidan but surprisingly, we observed the same 
behaviour as with fuco-NPs (figure 4.4). Indeed, two hours after injection, the 
concentration of PEG-NPs reached a maximum level, corresponding to a minimum of the 
MR signal as for fuco-NPs (figure 4.5). The difference in behaviour with CMD-NPs 
could not be explained by the only passive diffusion effect (Enhanced Permeation and 
Retention Effect) of the NPs [162, 163] since CMD-NPs which are similar in size to 
PEG-NPs did not induce a contrast enhancement. However the zeta-potential of PEG-
coated NPs (-8.4 mV, see appendix G) was not so negative that the NPs could be quickly 
taken up by diseased tissues which cells have negative surface charge [164, 165, 166]. 
Because CMD-NPs have zeta-potential of -33.3 mV which was high enough to avoid 
absorption by the thrombus they were not expected to link to the thrombus. 
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Figure 4.4. MRI of atherothrombosis after PEG-NPs injection. 
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Figure 4.5. MR signal after NPs injection versus time. 
All these results demonstrated the capability of Zn(Fe)O-based fucoidan-coated NPs to 
be used as a contrast agent biospecific of atherothrombosis. 
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4.2. Optical imaging 
Structure of a healthy vessel and vessel with atherothrombosis were imaged by 
brightfield microscopy, dark field microscopy, hyperspectral microscopy, fluorescent 
microscopy, second-harmonic imaging microscopy and differential interference contrast 
microscopy. Each microscopy method gave some specific information about the structure of 
the atherothrombosis and the vessel. 
4.2.1. Perls’ Prussian Blue Staining 
Perls’ Prussian Blue Staining was performed on some histological slices of diseased 
tissues from animals which have been injected with fucoidan-coated NPs. The  
Figure 4.2 evidenced the presence of NPs since Perls’ reaction allows to colour iron 
ions (blue dots). This method can provide a proof of the presence of aggregated NPs. This is 
not a sensitive method, and it cannot be used to detect single NP. 
 
Figure 4.2. Iron distribution (blue dots) in vessel wall. L = lumen of the vessel.  
4.2.2. Healthy vessel and diseased vessel  
We compared images of a healthy vessel without atherothrombosis and a diseased 
vessel. Bright field and dark field imaging showed the difference of them. In 
autofluorescence images (Figure 4.5), the bright area inside the vessel wall, could evidence 
collagen, which has a strong fluorescence emission [171]. 
L 
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Figure 4.3. Bright field imaging of a healthy vessel (left) and a diseased vessel (right), 
W= Wall; L=Lumen; T=Thrombosis.  
     
Figure 4.4. Dark field imaging of a healthy vessel (left) and a diseased vessel (right). 
   
Figure 4.5. Bright field imaging (left) and fluorescence imaging (right) of a healthy vessel. 
  
W 
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4.2.3. Images of atherothrombosis 
Bright field images Dark field images Fluorescence images Hyperspectral 
images 
  
Figure 4.6. Bright field, dark field, fluorescence, hyperspectral images of atherothrombosis. 
The dotted lines encircle diseased areas, the yellow dash line could be fibrin, the white plain 
lines can be collagen fragments, and the white arrow is probably NPs, W= Wall; L= 
Lumen; T=Thrombosis. 
While using bright field microscopy, we investigated histological structure of the 
tissue. The diseased areas are marked with a red-dotted line within a high density of blood 
1a 1b 1c 1d 
2a 2b 2c 2d 
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4a 4b 4c 4d 
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tissue. Fibrin rich area could be encircled by the yellow dash line as a sign of early 
atherothrombosis development (Figure 4.6.1a, 2a, 3a). 
Dark field microscopy is also suitable to investigate structure of the tissue. Because the 
very high contrast of this method, dots could be detected whereas they could not be seen in 
bright field microscopy. The dots could be clusters of NPs or cell nucleus, which were both 
strongly scattering under laser light (Figure 4.8, Figure 4.6.1b, 2b, 4b). 
Because fluorescence of NPs was weaker than that of tissues, the distribution of NPs 
in the histological tissues was rather difficult to obtain. However, autofluorescence images 
could detect weak points of the vessel or an inflammation area where one could find a high 
concentration of collagen fragments. Collagen fragments were strong fluorophores, so they 
could easily be seen on the fluorescence image (white plain line in Figure 4.6.2c, 3c). 
In the fluorescence image of atherothrombosis, some bright area could be seen (white 
arrows in Figure 4.6.4c) as large concentrations of NPs. The total intensity was rather weak, 
but we could still distinguish something different from the neighbouring autofluorescence. 
With hyperspectral microscopy, the image of atherothrombosis had a better contrast, 
and gave clues about different materials in the samples by analyzing the signal of tissue. 
The weak point of the vessel (orange dash line in Figure 4.6.2d) could be seen clearly by 
hyperspectral imaging. We could see different structures of the vessels and the 
atherothrombosis which could not be obtained by bright field images (orange dash line in 
Figure 4.6.2d, orange arrow in Figure 4.6.4d). 
    
Figure 4.7. Second-harmonic images of atherothrombosis, W= Wall; T=Thrombosis. 
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To finish with, we also tested other imaging modalities in collaboration with the team 
of Marie-Claire Schanne-Klein at Laboratoire d’Optique Biomédicale (LOB), Ecole 
Polytechnique. We thus imaged samples with second-harmonic imaging microscopy 
(SHIM) and differential interference contrast (DIC) microscopy. Atherothrombosis could be 
clearly imaged. However NPs could not be evidenced because of strong autofluorescence of 
tissues and weak emission from NPs (Figure 4.7, Figure 4.8). 
 
Figure 4.8. DIC image of atherothrombosis, W= Wall; T=Thrombosis. 
4.3. Conclusion 
The difference of MRI images between before and after injection with fuco-NPs and 
CMD- NPs, as a reference, confirmed that fuco-NPs were good T2 contrast agents. Although 
devoided of biospecificity, PEG--NPs behave as fuco- NPs, and we have no clear 
explanation to propose. Many different optical modalities were used to detect NPs in 
atherothrombosis but all the experiments did not succeed. The main reason was the weak 
fluorescence of NPs as compared to the strong autofluorescence of tissue. Because the NPs 
were interspersed among the tissue, so we could not distinguish signals from them. 
In table Table 4.1, we compare all the optical imaging method we used. The ability to 
allow the dectetion of NPs and the main drawbacks are shown. Dark field, hyperspectral, 
fluorescence spectroscopy were able to detect NPs. However, equipment and software must 
be improved to get more relevant results. Eventually, according to my opinion, fluorescence 
remains the best tool for NPs detection. 
 
 
W T 
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Table 4.1. Comparing optical imaging method 
 Bright field  Dark field  Hyperspectral Fluorescence 
Contrast Low High High High 
Additional 
hardware 
No External light 
sources 
Monochromator 
External light 
sources 
Laser 
Filters 
Additional 
Software 
No No Yes No 
Speed Real-time Real-time Non real-time Real-time 
Additional 
Labeling 
No No No Yes 
Ability to 
detect NPs 
No Yes Yes Yes 
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General discussion 
The early diagnosis of atherothrombosis with clinical imaging would allow both a 
most suitable follow-up and the establishment of appropriate therapeutic strategies. 
Nowadays, the field boasts a plethora of nanoparticulate systems to improve the quality of 
the images (contrast agents) [172]. However, some key points must be addressed for the 
design of NPs for these purposes  [173, 174]: (i) a hydrodynamic size below 100nm and a 
size distribution as narrow as possible due to the fundamental size dependent properties of 
NPs, (ii) good dispersion, stability and biocompatibility by means of robust hydrophilic 
coatings that induce a strong steric repulsion between NPs to extend the residence time in 
circulating blood and to limit endocytosis by macrophages, (iii) the specificity for the 
intended target. In parallel, the development of multimodal clinical imaging systems (for 
example PET/MRI and SPECT/CT) would improve diagnostic and the understanding of 
cell-scale and even molecular-scale events through high quality images in terms of 
sensitivity and resolution. Finally, the coupling of nanosystems with ligands of pathological 
biomarkers would considerably improve their action by limiting the side effects. 
For the last 20 years some studies focused on the preparation ZnO-based NPs due to 
unique magneto-optic properties [1, 175, 176, 177, 178, 179] which were very attracting for 
biomedical applications [3, 180, 181, 182, 183]. In our study, we prepared Zn(Fe)O NPs 
combining fluorescent and magnetic properties in the same core [1, 2, 179, 184, 114] which 
were coated with fucoidan in order to perform bimodal magnetic resonance and optical 
imaging of atherothrombosis. Our main objective was thus to develop optical imaging 
protocols for the observation of the nanoparticles on tissue slices in order to further link 
their localization and their “behaviour” to the biological pathological environment. This was 
done in the continuity of the works of Nguyen Trong Nghia published in Journal of 
Biomedical Optics in 2017 [111]. 
We have performed numerous experiments to get inorganic nanocrystals endowed 
with the required properties, which efficient and easy obtainment remains a challenge [185, 
111]. NPs have been quantitatively obtained from zinc acetate and iron acetate mixture in 
diethylene glycol with RFe=Fe/(Zn+Fe) (mol/mol) ranging from 0.05 up to 0.5 by a novel 
azeotropic method using toluene to remove water from the reaction mixture. The azeotropic 
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method allowed the formation of high crystalline quality nanocrystals with narrow 
polydispersity and size ranging from about 3 to 8 nm, much smaller than in previous studies 
with the presence of water in the reaction medium [3, 125, 126, 124, 127]. XRD evidenced 
high doping levels of wurtzite ZnO phase with iron ions up to RFe=0.35 [186, 2] (namely 
DEG-0.35). However, NPs prepared with RFe=0.5 (namely RFe, I = 0.5) were corresponding 
to a mixture of nanocrystals of same size made of wurtzite phase (45% w/w) and spinel 
cubic phase (55% w/w), the latter likely corresponding to the formation of ZnFe2O4 [144, 
114, 146]. RFe, I = 0.5 NPs were coated with carboxymethyldextran (CMD-0.5) and fucoidan 
(fuco-0.5) for further animal experiments; fucoidan was recently used as a molecular ligand 
in for SPECT imaging and MRI of atherothrombosis and heart ischemia [160, 34, 35, 161]. 
Coated NPs had size on the hundreds of nanometer scale and negative charge surface 
evidencing the coating with the anionic polymers. They were ferromagnetic with saturation 
magnetizations of about 22-25 emu/gram and were evidenced as T2 MR contrast agents. 
When excited at 370 nm, they exhibited a broad fluorescence emission at about 470 nm. 
The animal experiments showed that fuco-NPs could be used as MR contrast agent for 
imaging atherothrombosis. Indeed, two hours after injection, a maximum contrast was 
obtained which was attributed to the interaction of fuco-NPs with P-selectin overexpressed 
by aggregated activated platelets [161, 34]. indicating that Zn(Fe)O-based NPs have the 
potential to be effective T2 contrast agents 
The dark field microscopy allowed us to locate NPs, tracking their movements, 
estimate their size in a liquid medium. Using 15 mW focused He-Ne laser and an ultra-low 
noise, highly sensitive EMCCD camera, the bare NPs with hydrodynamic diameter near 30 
nm could be seen by dark field microscope. This is nearly the limit of this method (10 nm) 
[150]. Some other groups report NPs could be tracked at a size of 60 nm [187, 188]. The 
Brownian motion of NPs can be followed and the size of the NPs is estimated in real-time 
with our homemade software. NTA have already been reported in some publications, where 
NPs can be tracked in a cell, but the NPs size was rather big: 50-100 nm [189, 190] . 
We have developed a three-dimensional (3D) single-particle tracking system using 
dark field interference microscopy. We have a high resolution in x and y, and the scanning 
depth along z axis is up to 100 µm. The precise location of NPs can be determined with 
single shot image by using a convolution image algorithm. 
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Dark field hyperspectral microscopy is also a very good tool for locating NPs in the 
histological tissue. It collects and processes information from electromagnetic spectrum of 
the images. By analyzing the spectrum of every pixel and comparing to the spectrum of 
reference materials, hyperspectral microscopy can detect the presence of nanomaterial on 
exposed tissue slices, locate, identify, and characterize them. The combination of 
hyperspectral imaging and dark-field microscopy made a new powerful tool providing 
images with better contrast and higher signal-to-noise ratio than images obtained by 
conventional dark field microscopy. A homemade dark field hyperspectral microscope was 
built and a program for analyzing data was studied and developed. 
We have performed experiments on histological slices of harvested diseased vascular 
tissue from rats. Structures of a healthy vessel and a vessel with atherothrombosis were 
imaged by brightfield microscopy, dark field microscopy, hyperspectral microscopy, 
fluorescent microscopy, second-harmonic imaging microscopy and differential interference 
contrast microscopy. 
Although we used high quality equipment such as a good microscope, a powerful 370 
nm – 20 mW UV diode laser, an ultra-low noise EMCCD camera, and special filters, we 
found it was very difficult to identify reliably the NPs in the tissue. 
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General conclusion and perspectives 
Nanoparticles (NPs) containing iron and zinc oxide which could be used as bimodal 
Magnetic resonance imaging (MRI)/optical contrast agents were synthesized by polyol 
method. Many experiments with different iron concentrations have been performed in order 
to get NPs from zinc and iron salts in polyol medium. An azeotropic method was developed 
which allowed the formation of Zn(Fe)O nanocrystals with sizes ranging from about 3.5 to 
8 nm and low dispersity, in good yields. XRD diffractogram showed the crystalline quality 
of NPs and evidenced a mixture of nanocrystals made of wurtzite and cubic phase for the 
highest iron content, although it was not possible to distinguish one from the other by TEM. 
Due to their magnetic properties, these NPs could be considered as contrast agents for MRI 
and they exhibited a large emission spectrum above 450 nm when excited at 370 nm. 
Fucoidan-coated NPs and carboxymethyl dextran-coated NPs were injected in a rat 
model of atherothrombosis. MR images evidenced the uptake of fucoidan-coated NPs into 
the diseased areas which were harvested and examined as histological sections by optical 
imaging modalities.  
In our study, different types of optical microscopies have been optimized with NPs in 
vitro before attempting their detection on histological sections of animal tissues. The 
structure of atherothrombosis was imaged by brightfield microscopy, dark field microscopy, 
hyperspectral microscopy, fluorescent microscopy, second-harmonic imaging microscopy 
and differential interference contrast microscopy. However, although we used good 
equipment such as a good microscope, a powerful 370 nm – 20 mW UV diode laser, an 
ultra-low noise EMCCD camera, and special filters, some promising area were found but 
the presence of NPs cannot be confidently asserted. The fluorescence of NPs was too weak 
as compared to that of tissues, a weakness which was magnified by the small size of the 
inorganic cores. 
Nevertheless, the new azeotropic method we have used in this work has made it 
possible to easily and quantitatively produce nanoparticles whose magnetic and optical 
properties make them potential contrast agents for bimodal imaging using MRI and optical 
microscopies. We consider our results as promising for further development of such 
nanomaterial if optical properties could be optimized. This optimization would implicate not 
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only to master the surface chemistry of the NPs but also the development of optical imaging 
setup such as dark field optical coherence tomography allowing 3D images reconstruction. 
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Appendix A. Characterization techniques  
Transmission electron microscopy 
Transmission electron microscopy (TEM) is a very useful tool for materials 
nanotechnology, semiconductor and medicine research because of its extremely high 
resolution. The shape and average size of the NPs can be determined quickly. Compared to 
optical microscopy, TEM has a much better in resolution because the wavelength of the 
electron beam, used as a wave, is much shorter than that of the visible light. The resolution 
of a TEM is about 0.2 nm. 
An electron gun uses a high voltage source (typically ~100-300 kV) to emit electrons 
either by thermionic or field electron emission into the vacuum. Electrons are selected to 
have a relatively narrow energy distribution, which is to have a beam reasonably 
monochromatic. Similarly to an optical microscope, the incident beam is shaped by a 
condenser. It then hits and passes through the sample. Other lenses play the role of the 
objective and the scattered electrons excite a fluorescent screen which produces a visible 
image. This visible image is recorded by a CCD camera. The layout of optical components 
in a basic TEM is shown in Figure A.1 [191]. The electron microscope is a lot more 
complex than the optical microscope. The electron beam needs a good vacuum to propagate 
into. Electrons interact and repulsion makes the beam self-defocusing. The lenses are in fact 
magnetic fields whose shapes are controlled by electrical currents. Good lenses are a lot 
more difficult to obtain than the polished glass lenses used in optical microscopes and TEM 
usually suffer from spherical aberration. However, since everything is defined through 
electrical currents, microcontrollers and good software can make the instrument extremely 
versatile. 
The main drawback is that samples must be very thin in order not to intercept the beam 
too much, about 100 nm thick, which is difficult to attain with biological samples. On the 
other side, if the sample is too clear, one must enhance the contrast with heavy atoms. 
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Figure A.1. Layout of optical components in a basic TEM. 
X-ray diffraction 
X-ray diffraction (XRD) is an analytical technique used for phase identification of a 
crystalline material and collecting information on unit cell dimensions. When an incident 
beam of monochromatic X-rays interacts with a target material, those X-rays are scattered 
from atoms in the target material. If the target materials have regular structure (i.e. 
crystalline, see Figure A.2), there are constructive interference in some specific directions 
when Bragg’s law is satisfied: 
2𝑑 sin 𝜃 = 𝑛𝜆          (A.1) 
where:  n is an integer, 
d is the spacing between diffracting planes, 
θ is the incident angle, 
λ is the wavelength of the beam. 
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Figure A.2. X-rays scattered by crystal. 
A powder X-ray diffractometer consists of an X-ray source, a sample holder, a 
detector and a way to vary angle θ. A narrow parallel monochrome X-ray beam is focused 
on the sample at angle θ, while the detector reads the intensity of the diffracted X-ray at 
angle 2θ (see Figure A.3). For typical powder diffractograms, data is collected at 2θ from 
~5° to 70°. 
The crystalline size of NPs is calculated using the most intense peak by Scherrer’s 
formula. 
𝐷 = ௄ఒ
ఉ೓ೖ೗ ୡ୭ୱ ఏ
          (A.2) 
where:  D is the size of the axis parallel to Bragg plane (hkl),  
K is a constant with a typical value of 0.9 for spherical particle,  
𝜆 is the wavelength of radiation,  
hkl is the full width half maximum (FWHM) in radians, 
θ is the position of the diffraction peak maximum.   
d 
d 
d 
d θ θ 
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Figure A.3. Schematic diagram of X-ray diffractometer. 
Fluorescence spectroscopy  
 
Figure A.4. Schematic diagram of fluorescence spectrophotometer. 
Fluorescence spectroscopy analyses fluorescence from a sample. The sample is excited 
by an excitation light beam and it emits fluorescent light. Schematic diagram of 
fluorescence spectrophotometer is shown in Figure A.4. All fluorescence instruments 
contain three basic items: a source of light, one or more monochromators and a detector. 
The light source has often a broad emission spectrum. It can be a xenon lamb or a halogen 
lamp. The light emitted by the broad spectrum lamp passes through a monochromator (or 
filters) for selecting the excitation light. A monochromatic laser beam can be used as a high 
intensity excitation source, with a very narrow spectral width. Another monochromator 
analyses the emission spectrum of the sample. 
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The light source is in a 90-degree angle with the detector to avoid light from excitation 
beam from hitting directly the detector with high power. Linear scattering occurs in the 
sample, but can easily be dealt with by the use of rejection filters. Sensitive detectors such 
as a photomultiplier tube, an avalanche photodiode or a CCD camera record the 
fluorescence light from the sample. 
Dynamic light scattering 
Dynamic Light Scattering (DLS, also known as Photon Correlation Spectroscopy) is a 
light scattering technique which allows NPs sizing down to 1 nm diameter. The basic 
principle is simple: The sample is illuminated by a laser beam and the fluctuations of the 
scattered light are detected at a known scattering angle θ by a fast photon detector (Figure 
A.5). 
 
Figure A.5. Schematic diagram of DLS. 
 Simple DLS instruments that measure at a fixed angle can determine the average size 
of NPs in a limited size range. More sophisticated instruments which combine multi-angle 
detectors can determine a large range of particle size distributions. 
By analysing the fluctuation of the scattered light, intensity correlation function g(2)(t) 
can be calculated as equation A.3 [192]. 
𝑔(ଶ)(𝜏) = 〈ூ(௧)ூ(௧ାఛ)〉
〈ூ(௧)〉మ
         (A.3) 
where I(t) and I(t + τ) are the intensities of the scattered light at time t and at a delayed 
time t + τ. The braces indicate averaging over t. 
If the sample is monodisperse then the decay is simply a single exponential: 
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 𝑔(ଶ)(𝜏) = 𝐵 + 𝛽 exp(−2𝛤𝜏)        (A.4) 
where:  B is the baseline of the correlation function at infinite delay,  
β is the correlation function amplitude at zero delay, 
𝛤 = 𝑞ଶ𝐷 is the decay rate. 
The diffusion coefficient D can be derived from the decay rate  at a single angle (or 
at a range of angles) depending on the wave vector q: 
𝑞 = ସగ௡బ
ఒ
sin ఏ
ଶ
          (A.5) 
where: n0 is the refractive index of the sample. 
Using diffusion coefficient D measurement, a particle size distribution can be 
determined via the Stokes-Einstein formula: 
𝐷 = ௞ಳ்
ଷగఎௗ
             (A.6) 
where:   D is the diffusion coefficient, 
  𝑘஻ is the Boltzmann constant (1.38x10-23 J/K), 
  T is the temperature, 
η is the viscosity of the dispersion medium, 
d is a hydrodynamic diameter. 
Hydrodynamic diameter is an effective diameter including both the diameter of the 
core particle and the diameter of layers on its surface. These layers can include polymers, 
electrical charges, actively interacting with the particle. In general, it will be larger than the 
TEM measured diameter. 
Vibrating sample magnetometer 
A vibrating sample magnetometer (VSM) is a scientific instrument that measures 
magnetic properties of a material, invented in 1955 by Simon Foner at Lincoln Laboratory 
of the MIT.  
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Figure A.6. Schematic diagram of a vibrating sample magnetometer. 
Schematic diagram of a vibrating sample magnetometer is described in Figure A.6. A 
sample is magnetized when placed inside a uniform magnetic field that is generated by an 
electromagnet or a superconducting magnet. Then the sample is mechanically excited by 
vibrating piezoelectric actuators. When the magnetized sample moves near the pickup coil, 
it changes the magnetic field and the magnetic flux ΦB through the coil. According to 
Faraday's Law, the induced voltage generated in the coil is shown in equation A.7:  
𝜀 = −𝑁 ௗథಳ
ௗ௧
          (A.7) 
where:  ε is the induced voltage, 
N is the total number of turns of the loop,  
ΦB = B.A, (B is the magnetic field, A is the area of the loop),  
t is the time. 
This voltage is proportional to the sample's magnetic moment. In a typical setup, the 
induced voltage is measured by using of a lock-in amplifier with the piezoelectric excitation 
signal as a reference. By changing strength of the applied magnetic field, it is possible to 
obtain the hysteresis curve of the sample’s material. 
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Appendix B. Microscopy basics 
Microscope is an optical device used for imaging small specimens with high-
resolution. Image quality mostly depends on the objective of the microscope, which 
determines the resolution of images. Here are some basic properties of microscope such as 
resolution, magnification, and type of illumination. 
Resolution 
The resolution of an optical system isn't the number of pixels in its output images. It is 
defined as the shortest distance between two points on the image the observer can still 
distinguish. 
For example, in Figure B.1, two airy diffraction patterns can be easily distinguished 
(a), still can be distinguished when they are not too close (b), and cannot be distinguished if 
the distance becomes too small (c). 
The ultimate resolution of a microscope (d) is determined by the wavelength of the 
radiation light (λ), and the numerical aperture (NA) of its light collecting system. It is 
mathematically given by the Abbe’s formula B.1 [193]:  
𝑑 = ఒ
ଶே஺
           (B.1) 
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Figure B.1. Airy patterns and the limit of resolution. 
For real, the resolution limit is somewhat greater than its theoretical limit because 
practical realization isn't perfect. For example, we can notice optical aberration of the 
lenses, misalignment of different subsystems, and so on. 
NA is the ability for collecting light by a lens. A high NA objective allows more 
efficient light harvesting. It gives better images. The NA value of a lens is calculated as 
equation B.2: 
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𝑁𝐴 = 𝑛 sin 𝜃           (B.2) 
where:  n is the index of refraction of the medium in which the lens is working, 
θ is the maximal half-angle of the cone of light that can enter or exit the 
lens.  
A microscope objective with a higher NA needs to be closer to the object than a lower 
NA one. NA values above 1.0 also indicate that the lens is immersed in a fluid, instead of air, 
which fills the small gap between it and the sample. Fluid immersion makes a better optical 
interface than air. 
Of course, shorter wavelengths will provide a better resolution. However, we have 
strong limits: usual optical systems aren’t friendly with UV light, and biological objects are 
easily damaged by short wavelength. 
Can we beat this resolution limit? 
Figuratively speaking, we can imagine we have a small genie in our bottle, a small 
oracle in our microscope. We have more than the usual three wishes; in fact we have as 
many wishes as we want. He’s a good genie as he is honest and doesn't try to mislead us. 
However, he is inflexible. As long as we ask anything wavey, it answers with the Abbe 
limit. If we want anything better, we must try other kinds of questions. 
We are certain that any structure in the object emits a characteristic signal. The genie 
has access to virtually an unlimited quantity of information. However, most of it is lost 
when the wave propagates towards our detector. 
Is it possible to get some parts of this complex information before it blurs away in the 
propagating wave? Yes, if we can take the information directly from the genie’s hands. It’s 
called “near field microscopy”. A local probe catches the transient evanescent signals and 
allows them to propagate, in the probe, to the detector. This technique however is strictly 
limited close to nice surfaces. Soft materials are difficult to deal with and one can only look 
at a very small volume as the field of depth is very restricted. 
We can proceed differently. Instead of trying to cheat the genie when collecting the 
answers, ask him very precise questions. If one has a way to create a “source” inside the 
sample, smaller than the Abbe limit, light collected from it is guaranteed to come from this 
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small region. Many clever ways have been devised for the “sources” and sub-resolution 
microscopy is a booming field now. 
The problem now is that we have to pave the observation volume with those sources, 
often millions of them (experienced people will ask many questions in parallel). We can 
systematically scan the volume, or follow some tiny particles which move and interact with 
the sample thus relaying some information to us. Anyways, we have to collect a huge 
amount of “images”, process the useful signal from them, and fuse them in a big picture. 
At this point, we have to get our own small genie. We have to train him to interact 
with the optical genie and to process all the individual tiny bits of information into a 
workable image. This small genie is usually called “software”. This genie is often 
maliciously compliant. You get the wrong answer as soon as the question is asked in a way 
which let the genie interpret it differently from your real intention. But at least, you can 
debug it and earn your nice images. 
As a side note, this leads us to a common question people may ask to the programmer: 
are you sure your results are correct? No. I can’t be. The thing can process billions of 
instructions per second. A single image needs minutes, even hours, of processing. No one 
can do it “by hand”. However, with proper unit test, and with known limit cases, one can 
have a good confidence in the software’s results. 
Magnification 
Magnification of a microscope depends on the magnifying power of both the objective 
and the ocular piece.  
Total magnification (M) is normally simply the product of the two, as equation B.3: 
𝑀 = 𝑀௢௕௝௘௖௧௜௩௘ × 𝑀୭ୡ୳୪ୟ୰        (B.3) 
Usual objective magnification power ranges from 4X to 100X and the common oculars 
magnification is 10X. As a result, the total magnification of a microscope ranges from 40X 
to 1000X. In fact, the useful magnification is limited by the Abbe limit on resolution. Best 
microscope can go up to 800X with air objectives and a little more than 1000X using 
immersion ones. The magnification factor is more useful for commercial purposes. 
Scientific imaging is more prone to use the resolution as its yardstick. 
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Bright field illumination 
Bright field illumination is very popular in optical microscopy. It corresponds to the 
first microscopes, which were designed as early as the 17th century. It is the simplest and 
most intuitive technique and it is still the most used setup today. A typical bright field 
illumination image has a dark sample with a white background. Some types of bright field 
illumination configurations are shown in Figure B.2. 
There are four main components in bright field illumination: 
+ The light Source can be any kind of source such as a laser, a halogen lamp, a xenon 
lamp or a light-emitting diode. The simplest setup just uses the sun reflected in a mirror. 
+ Condenser Lens:  focuses light from light source to the sample. 
+ Objective Lens: collects light from the sample. 
+ Eyepiece/Camera: views or records the image. 
The bright field illumination technique is simple. However, it has some disadvantages. 
The most important one is that it provides low contrast images. No signal corresponds to the 
light's maximum intensity. The sample absorbs whatever light corresponds to its optical 
thickness and, usually, transmitted light is far from zero. We cannot amplify the useful 
signal as the bright empty field is already near the sensor saturation. We cannot use the full 
dynamic range of the sensor, hence the bad contrast. This technique is suitable for thick and 
big samples, but not for thin and small ones. 
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Figure B.2. Some type of bright field illumination configurations: transmission (left) and 
reflection (right). 
Dark field illumination 
Dark field illumination is an arrangement such that the light source cannot directly hit 
the camera or the eyepiece. When light hits an object, it is scattered in all directions. The 
design of the dark field microscope removes the non-scattered light from light source and 
just only collects the scattered light from samples. 
A dark field microscope can provide beautiful and amazing images. The dark field 
illumination image has a bright sample with a black background. No signal now 
corresponds to zero, the black background. Even if the objects scatter little light, we can 
have amplification in the detector. Even if amplifications bring its own noise (you see video 
noise if you take photographs in a dark environment), this technique is a far better use of the 
sensor's dynamic range than the previous white field technique. A dark field microscope is 
ideal for viewing objects that are unstained, transparent and absorb little or no light such as 
fibers, minerals, ceramics, thin polymers, NPs, living bacteria, mounted cells and tissues. 
Offering a very high contrast, this microscope can allow us to detect very small target, even 
as small as NPs. 
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Besides the above mentioned advantages, dark field microscopy suffers from some 
drawbacks: 
+ It is not suitable for thick specimen, 
+ The slices must be cleaned very carefully to get rid of small particles such as dust. 
+ Control and operation are more complicated than those required by bright field. 
Dark field microscopy has many applications. It could be a wonderful observation 
tool, especially when combined with other enhancements. 
Conversion of a microscope from bright field to dark field  
A bright field microscope can be converted to a dark field microscope by using proper 
optical element such as a condenser with a beam stopper, or with an external light source. 
Some dark field kits are commercially available for this retrofit of a classical microscope. 
In Figure B.3, the left-hand side shows a setup which is commonly used for 
commercial dark field microscopes. It is the most popular configuration because it is 
compact and requires minimal modifications in the microscope. The right-hand side 
configuration for a dark field microscope is usually used as a homemade microscope 
because it has a good ability to collect light, is inexpensive and offers further upgradability, 
even if its intrinsic resolution is a little worse than the one offered by the first configuration. 
Figure B.4 indicates the difference between a bright field image and a dark field one in 
term of contrast. 
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Figure B.3. Some types of dark field illumination configuration. 
    
Figure B.4. Bright field illumination image (left) and dark field illumination image (right) 
of vessel. 
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Appendix C. List of synthesis NPs experiments 
Table C.1. List of synthesis NPs experiments in DEG 
RFe, i 
(%)  
Compound 
(mol) 
Drying N2 Solvent Temp. 
(oC) 
Time  
(h) 
Yield 
(*) 
Coating Analysis 
0 Zn(Ac)2:  
0.02 
Vacuum no DEG Reflux 6 ** no Xray, 
TEM 
0.01 Zn(Ac)2: 
 0.02  
Fe(Ac)2:  
0.0002 
Vacuum no DEG Reflux 6 ** no TEM 
0.1 Zn(Ac)2:  
0.02  
Fe(Ac)2: 
 0.002 
Vacuum no DEG Reflux 6 ** no Xray, 
TEM 
0.2 Zn(Ac)2: 
 0.02  
Fe(Ac)2: 
 0.004 
Vacuum no DEG Reflux 6 ** no TEM 
0.05 Zn(Ac)2: 
 0.019  
Fe(Ac)2:  
0.001 
toluene  
 
yes DEG 230 4 *** Yes Xray, 
TEM 
0.1 Zn(Ac)2:  
0.018  
Fe(Ac)2: 
0.02 
toluene 
 
yes DEG 230 4 *** no AAS 
0.15 Zn(Ac)2:  
0.017  
Fe(Ac)2: 
 0.03 
toluene 
 
yes DEG 230 4 *** Yes Xray 
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0.2 Zn(Ac)2:  
0.016  
Fe(Ac)2: 
 0.004 
Toluene yes DEG 246 4 *** no Xray 
TEM 
AAS 
0.35 Zn(Ac)2:  
0.013 
Fe(Ac)2: 
 0.007 
toluene 
 
yes DEG 230 4 *** Yes Xray 
0.5 Zn(Ac)2:  
0.01  
Fe(Ac)2:  
0.01 
toluene 
 
yes DEG 230 4 ***** Yes Xray, 
TEM 
0.5 Zn(Ac)2: 
 0.01  
Fe(Ac)2:  
0.01 
toluene 
 
yes DEG 240 4 ***** Yes VSM 
0.5 Zn(Ac)2: 
 0.01  
Fe(Ac)2: 
 0.01 
Toluene yes DEG Reflux 4 ***** yes Xray, 
TEM, 
AAS 
 
  
 115 
 
Table C.2. List of synthesis NPs experiments in PG 
RFe,i 
(%) 
Compound 
(mol) 
Drying N2 Solvent Temp. 
(oC) 
Time  
(h) 
Yield 
(*) 
Coating Analysis 
0 Zn(Ac)2: 
0.03 
no yes PG Reflux 2 ***** no TEM 
0 Zn(Ac)2: 
0.03 
Toluene yes PG Reflux 2 ***** no TEM 
0 Zn(Ac)2: 
0.02 
Toluene yes PG Reflux 2 ***** no TEM 
5 Zn(Ac)2: 
0.02  
Fe(Ac)2: 
0.001 
Toluene yes PG Reflux 2 ***** no AAS 
10 Zn(Ac)2: 
0.018  
Fe(Ac)2: 
0.02 
toluene  
 
yes PG 188 2 ***** no AAS 
20 Zn(Ac)2: 
0.016  
Fe(Ac)2: 
0.004 
Toluene yes PG 188 2 ***** no Xray, 
TEM, 
AAS 
50 Zn(Ac)2: 
0.01  
Fe(Ac)2: 
0.01 
toluene  
 
yes PG 187 2 ***** no VSM 
AAS 
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Table C.3. List of synthesis NPs experiments in mixture of DEG/PG 
RFe,i 
(%) 
Compound 
(mol) 
Drying N2 Solvent 
 
Temp. 
(oC) 
Time  
(h) 
Yield 
(*) 
Coating Analysis 
5 Zn(Ac)2: 
0.019  
Fe(Ac)2: 
0.001 
toluene  
 
yes DEG:  
60 
PG:  
30 
220 4 ***** no AAS 
30 Zn(Ac)2: 
0.02  
FeCl2: 
 0.01 
toluene 
 
yes DEG: 
 80 
PG: 
40 
220 4 * no  
50 Zn(Ac)2: 
0.01  
Fe(Ac)2: 
0.01 
toluene 
 
yes DEG:  
65  
PG: 
15 
190 4 ***** no AAS 
50 Zn(Ac)2: 
0.01  
Fe(Ac)2: 
0.01 
toluene 
 
yes DEG:  
80 
PG: 
5 
240 4 ***** no AAS 
67 Zn(Ac)2: 
0.005  
Fe(Ac)2: 
0.01 
Toluene yes DEG:  
60 
PG: 
30 
218 4 ***** no AAS 
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Appendix D. Synthesis of ZnO NPs in PG without azeotropic distillation 
0.02 mol of zinc acetate dehydrate (Zn(CO2CH3)2. 2H2O, 98.0%), was dissolved in 80 
ml of PG heated to reflux (187oC). In this synthesis, we did not use Na+ and there is 
unknown amount of water in acetate salt and PG solution. After 2 hours, a suspension of 
NPs was obtained. The chemical reaction in PG can produce NPs with very high yield 
(>98%). The weight of NPs obtained after synthesis is a little heavier than calculated theory 
weight. The TEM images show the mean size of PG-ZnO NPs is 120 nm (Figure D.1). 
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Figure D.1. TEM images and size distribution of PG-ZnO NPs with water.  
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Appendix E. Synthesis of NPs in DEG without azeotropic distillation 
Zn(Fe)O NPs (RFe = (0, 0.01, 0.1 and 0.20) were synthesized with DEG as solvent 
0.02 mol of zinc acetate and iron II acetate was dissolved in 80 ml of DEG. The solution 
was heated to reflux. After 4 hours, a suspension of NPs was obtained. The influent of 
catalyst Na+ to size and crystalline quality were also investigated. 
 With catalysts 
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Figure E.1. TEM image and size distribution of DEG-ZnO NPs with catalysts.  
ZnO NPs were synthesized with catalyst Na+ (NaOH, NaAc). In TEM images 
indicated that the average diameter of NPs is about 50 nm with broadband distribution 
(Figure E. 1). The shape of NPs is rod with the length up to hundreds nanometer. The XRD 
spectral show the crystal quality of NPs (Figure E.2).  
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Figure E.2. XRD diffractogram of DEG-ZnO NPs synthesized with Na+. 
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Because DEG is a hygroscopic liquid, there is amount of water in precursor and 
unknown amount of water in DEG. With catalyst Na+ and water, the chemical reaction is 
probably too fast, it leads to an uncontrolled crystal growth at different directions.  
With dried salt 
In those experiments, we slowed down the synthesis rate, by dismissing catalysts 
(Na+). Zn(Fe)O NPs (RFe = (0, 0.01, 0.1 and 0.20) were synthesized with dried acetate. 
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Figure E.3. TEM image and size distribution of DEG-ZnO NPs with dried salt. 
TEM and size distribution of ZnO NPs with dried salt shows that the NPs is uniform in 
size and shape and the average diameter of pure ZnO NPs is about 20 nm (Figure E.3).  
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Figure E.4. TEM image and size distribution of DEG-0.01 with dried salt. 
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Figure E.5. TEM image and size distribution of DEG-0.2 with dried salt. 
The TEM images of  Zn(Fe)O NPs RFe = 0.01 and 0.2 ( Figure E.4, Figure E.5) show 
that the NPs is round shape, average size is 8 nm and narrow distribution. XRD 
diffractogram of pure Zn(Fe)O (RFe = 0 and 0.1) is shown in Figure E.6. 
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Figure E.6. XRD diffractogram of pure ZnO and DEG-0.1. 
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Appendix F. Carboxymethyl pullulan synthesis 
Carboxymethyl pullulan (CMP) synthesis 
1 g of pullulan (Hayashibara, Japan) was mixed with 1.35 g powder of sodium 
hydroxide, followed by the addition of 8 ml of propan-2-ol and 2 ml of water. It was then 
mixed with a solution containing 1.5 g of monochloroacetic acid in 2 ml of propan-2-ol. The 
pullulan carboxymethylation was carried out under stirring (200 rpm) at room temperature 
for 4 hours. The reaction was then stopped by adding 50 ml (70%) water ethanol (v / v) to 
the mixture. The CMP was filtered off, washed four times with (70%) ethanol-water (v / v) 
and diethyl ether before being dried overnight at 50 °C under vacuum to give white powder 
with a yield of 70%. 
Determination amount of CM in CMP 
 The degree of substitution (DS) of the carboxymethyl groups (CM), which relative to 
number of CM per unit of pullulan anhydroglucose, was obtained by conductometry. 
First, approximately100 mg of CMP was dissolved in 100 ml of HCl (0.05 M) and the 
pH adjusted to about 2.0 with dilute NaOH. The solution was then titrated with NaOH 
(0.05M). The titration curve is presented in Figure F.1. The first part of the curve (below 
V1) corresponds to the neutralization of the H+ ions originating from the strong HCl acid 
initially added, the plateau (from V1 to V2) is due to the neutralization of the carboxylic 
groups, while the last increase in conductivity (above V2) corresponds to an excess amount 
of NaOH.  
The number of moles of CM is equal to that of NaOH in volume V2-V1 (VNaOH). The 
degree of substitution (DS) of CM can be calculated from 5 titrations in Table F.1. The 
results indicate that DS of CM is 1. 
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Figure F.1. Determination amount of CM in CMP 
Table F.1. The degree of substitution of CM 
Fraction 
V  
NaOH 
(ml) 
n 
CM 
(mmol) 
m  
CMP 
(mg) 
n  
CMP 
(mmol) 
c  
CM 
(mmol/g) 
DS  
CM 
1 10.2 0.510 107.7 0.6262 4.7354 0.81449 
2 10.3 0.515 107.7 0.6262 4.7818 0.82247 
3 14.8 0.740 100.4 0.5837 7.3705 1.26773 
4 12.9 0.645 107.7 0.6262 5.9889 1.03008 
5 13.9 0.695 107.7 0.6262 6.4531 1.10994 
Average     5.86593 1.00894 
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Figure F.2. Size distribution of CMP-0.50 NPs. 
We coated our NPs with CMP. We measured the hydrodynamic diameters and the 
zeta-potentials of CMP-NPs with DLS (see Figure F.2). The results indicated that the size of 
CMP-NPs was about 145 nm with a charge surface of -24.8 mV. After 3 months, this value 
did not change evidencing the excellent stability of the suspension. 
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Appendix G. Characterization of PEG-NPs 
Polyethylene glycol with phosphonic acid and carboxylic acid end groups (M=2500 
g/mol, Specificpolymers) is one relevant polymer to graft on nanoparticles which PEG 
chain could limit early elimination in vivo. Its phosphonate group would allow strong 
interaction with Zn and Fe ions at the surface of the NPs and carboxylic end group ensures 
solubility in neutral pH water. It also offers grafting possibilities. 
Hydrodynamic size and stability 
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Figure G.1. Size distribution of PEG-0.50. 
The DLS results indicate that the size of PEG-0.50 was about 135 nm (Figure G.1), 
with zeta-potential of -8.4 mV, in good agreement with carboxylic end groups on PEG 
chain. 
 Magnetic properties 
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Figure G.2. Magnetization (M) versus applied field (H) of DEG-0.50 and PEG-0.50. 
The saturation magnetizations of PEG-0.50 was 20 emu/gram (see Figure G.2). 
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Infrared absorption spectroscopy   
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Figure G.3. Infrared absorption spectra of PEG-0.50. 
FT-IR spectral evidenced PEG coating in the studied samples (Figure G.3). 
Thermogravimetry analysis 
 
Figure G.4. Thermogram of PEG-0.50. 
By analyzing thermogram, we determined that PEG-0.50 contained 58.5% of organic 
coating (Figure G.4). 
  
TG 
dTG 
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Appendix H. Characterization of fucoidane-NPs with different Fe concentration 
We determined the magnetic properties of the coated NPs at 300 K when the applied 
filed ranged from −30 to +30 kOe. Hysteresis plots show the variation of magnetization (M, 
emu/g) as a function of applied magnetic field (H, Oe).  
The magnetism properties of fucoidan-coated NPs with different Fe concentration 
were investigated (Figure H.1). The results indicated that fuco-NPs (RFe, I = 0.05, 0.15, and 
0.35) are paramagnetic and fuco-0.50 are superparamagnetic. 
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Figure H.1. Magnetization (M) versus applied field (H) curves of fuco-NPs with different Fe 
concentrations.  
We measured the absorbance spectra of fuco-NPs with different Fe concentration. The 
results indicated that the absorption wavelength was in UV band. With low concentration of 
iron, the fuco-0.05 had a peak at 270 nm corresponding to the band gap of zinc oxide. For 
higher concentrations of iron, the peak at 270 nm was less pronounced (Figure H.2). 
  
 126 
300 400 500 600 700 800 900
0.0
0.5
1.0
1.5
 
 
Ab
so
rb
an
ce
Wavelength(nm)
 Fuco-0.05
 Fuco-0.15
 Fuco-0.50
 
Figure H.2. Absorption spectra of fuco-NPs with different Fe concentrations. 
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Figure H.3. Fluorescence spectra of fuco-NPs with excitation wavelengths of 270 nm 
(left) and 370nm (right) with different Fe concentrations.  
The fluorescence intensity of coated NPs show that with higher concentration of Fe we 
had a lower fluorescence intensity (Figure H.3). 
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Figure H.4. Infrared absorption spectral of bare NPs and Fu-NPs with different Fe 
concentration.  
Infrared absorption spectral evidenced fucoidan in the samples (Figure H.4).  
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Appendix I. TEM images, size distribution and XRD spectra 
RFe TEM images Size distribution XRD 
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Figure I.1. TEM images, size distribution and XRD spectra of NPs. 
TEM images, size distribution and XRD spectra of NPs with different concentration of 
Fe is presented in Figure I.1.  
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Appendix J. XRD analysis report 
The results of XRD analysis are gathered in Table J.1. Stoechiometric formulae 
proposed with our hypothesis have been added in bold characters on DEG-0.35 and DEG-
0.5 panels. Rietvelt refinements have been performed with MAUD software and JCPDS 
card from Zn0.82 Fe0.123O which allow the best fit with experimental data. 
Table J.1. XRD analysis report 
 
 
DEG-0.05 
Lattice parameters (nm): a: 0.325839±6.68E-5; c: 0.53225±2.05 E-4 
Coherent domains of diffraction 
(nm): 5.862±0.18 
Microstrain : 1.79 E-2±3.87 E-4 
DEG-0.1 
Lattice parameters (nm): a: 0.32691±3.7 E-5; c: 0.52280±8.9 E-5 
Coherent domains of diffraction 
(nm): 6.965±0.09 
Microstrain : 8.1 E-3±1.7 E-4 
DEG-0.15 
Lattice parameters (nm): a: 0.327126±4.6 E-5; c: 0.52281±1.156 E-4 
Coherent domains of diffraction  
(nm): 6.726±0.05 
Microstrain:  8.6 E-3±8.55 E-5 
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DEG-0.35 
JCPDS : Zn0.82 Fe0.123 O   
Lattice parameters (nm): 
 
a: 0.327094±2.83 E-5;  
c: 0.531681±2.83 E-5 
Coherent domains of diffraction 
(nm) 5.78±0.22 
Microstrain: 1.93 E-2±2.29 E-4 
  
DEG-0.5 
JCPDS : Zn0.82 Fe0.123 O  
Lattice parameters (nm): 
a: 0.32499±1.78 E-4;  
c: 0.530024±3.87 E-4 
Coherent domains of diffraction 
(nm) /  phase % (Volume-Weight) 
3.85±0.36 
33.4 ±0.46%  _  44.88% 
Microstrain: 8.26 E-3±2.07 E-3 
Zn Fe2 O4   
Lattice parameters (nm): 
a: 0.84752±4.39 E-4 
Coherent domains of diffraction 
(nm) /  phase % (Volume-Weight) 
4.07±0.1 
66.6 ±0.86%_55.12% 
Microstrain: 8.11 E-5±4.33 E-3 
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Appendix K. Gaussian fit and center of mass method 
In this part, the speed and accuracy of Gaussian fit with least squares method and 
center of mass method were investigated with simulation data. 
Using a Monte Carlo method, we simulated the Gaussian image of NPs received by a 
CCD camera. We used two algorithms to determine the position of the NPs. By comparison 
between the simulated location of NPs and the locations calculated by the two algorithms, it 
is possible to evaluate the accuracy of these methods. 
Single NP can be seen via microscopy if the number of photons emitted is large 
enough compared to the background noise. The 2D image of a NP is related to the Airy disk 
(a cut of the PFS - Point Spread Function of the imaging system). Because the Airy disk is 
similar to a Gaussian function, we used in this simulation a Gaussian approximation in order 
to reduce computing time. 
Noise is an unwanted signal in measurements. Noise in the images obtained from the 
CCD camera may be due to thermal noise, intrinsic sensor noise, background noise that 
causes errors in locating process. 
Using a Monte Carlo method, we simulated some images of NPs in 2D Gaussian 
distribution with several intensities and a noise which are similar to the parameter obtained 
in real images captured by the CCD camera. Simulated images of NPs with different 
collected photons count and noise are shown in Figure K.1. 
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Figure K.1. Simulated image of NPs with different collected photons count and noise. 
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Data without noise 
Here we study images without noise and with 1000 incoming photons for each NP 
simulation. The number of NPs surveyed is 10000. We look at the error and the calculation 
speed of each of the two algorithms.  
 
Figure K.2. Error histograms of the center of mass method algorithm (left) and of the 
Gaussian fitting method algorithm, without noise. 
The results show that the error of the center of mass method algorithm is 0.047 pixel 
and elapsed time for every calculating is 9 ms. The error of the Gaussian fitting method is 
0.054 pixel and the elapsed time for each run is 24 ms. Center of mass seems to be a little 
better and a lot faster (Figure K.2). 
Data with shot noise 
Simulated images were added with shot noise with the SNR equal to 1. 1000 incoming 
photons are allowed for each NP simulation. The number of NP suveyed is 10000. The 
results show now that the error of the center of mass method algorithm is 0.071 pixel 
whereas the error of Gaussian fit method is 0.054 pixel (Figure K.3). Time is unchanged. 
 
Figure K.3. Error histogram of the center of mass method algorithm (left) and the 
Gaussian fitting method algorithm, with shot noise. 
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Data with shot noise and background 
Again, we simulated images with a shot noise at a SNR equal to 1. We add a DC noise 
with SNR equal to 0.5. 1000 incoming photons are played for each NP simulation. The 
number of NP suveyed is 10000. 
 
Figure K.4. Error histogram of the center of mass method algorithm (left) and the 
Gaussian fitting method algorithm, with shot noise and background 
The results show now that the error of the center of mass method algorithm is 0.07 
pixel and the error of Gaussian fit algorithm is 0.073 pixel (Figure K.4). With the same 
range of error, the computation time of the center of mass method (9 ms) is much lower than 
that of the Gaussian fitting by the least squares method (24 ms).  
Number of incident photons 
In Figure K. 5, we can see that, if the collected photons count is less than 5000 
photons, the center of mass is more accurate. The Gaussian fit algorithm gives beter better 
results with more than 5000 photons. The center of mass is a very good algorithm for 
quickly locating NPs with subpixel resolution. With its very fast estimation time, this 
algorithm is suitable for tracking NPs in real-time. 
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Figure K.5. Error of the Gaussian fit algorithms and the center of mass algorithms versus 
the number of incoming photons  
 134 
Appendix L. Accuracy of the 3D location algorithm 
Data simulation 
We used again a Monte Carlo method in order to simulate the interference images of 
NPs as seen by the CCD camera. From the simulation of the location of the NPs and their 
distance from the focus plane, it is possible to study the accuracy of our image correction in 
3 dimensions. The noise level is fixed at 100 photons for each simulation. The simulated 
interference images at a distance equal to 30 µm from the focus plane with different signal 
to noise ratio (SNR) values in Figure L.1.  
    
              (a)                            (b)                           (c)                             (d) 
Figure L.1. Simulated interference images of NP versus SNR: 10 (a), 100 (b), 1000 (c), and 
10000(d) 
Accuracy versus noise 
By definition, noise is an unwanted signal in measurements. Noise in the images 
obtained from the CCD may be due to thermal noise, electronic noise in the camera itself, 
background noise that cause errors in the locating process. As the results of our simulations 
of interference images, as a function of the SNR, show, the SNR value should be better than 
10 for sub-pixel accuracy. Interference images of NPs at several distances from the focus 
plane (z) were also simulated (SNR =1000). The results of simulations indicate that the 
vertical limit for subpixel resolution ranges from 5 to 50 µm (Figure L.2). 
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Figure L.2. Error versus SNR (left) and distance to focus plane (right). 
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Appendix M. Matlab code for hyperspectral microscopy imaging 
clear all; 
close all; 
 
BackGround = double(imread('BackGround.tif')); %Load  Back Ground image 
load 'NanoSpectrum.mat';                        % Load spectrum of NPs 
load 'LampSpectrum.mat';                        % Load spectrum of lamp 
 
FileDir='F:\hyper\znodata1\'; 
FileType='.tif'; 
FormatOfNumber='%d'; 
FileCounter=0; 
NumberOfFile=630; 
NumberString=sprintf(FormatOfNumber,FileCounter); 
FileName=sprintf('%s%s%s',FileDir,NumberString,FileType); 
  
IMGRaw= double(imread(FileName)); 
[nr,nc]=size(IMGRaw); 
cube=zeros(nr,nc,NumberOfFile); 
 
%******************************************************************* 
% Build wavelength array 
startwave=400; 
WlStepRatio=0.79365; 
wavearray=(0:NumberOfFile-1)*WlStepRatio+startwave; 
 
%******************************************************************* 
% Build cube of image versus wavelength 
FileCounter=0; 
while (FileCounter<NumberOfFile) 
        NumberString=sprintf(FormatOfNumber,FileCounter); 
        FileName=sprintf('%s%s%s',FileDir,NumberString,FileType); 
        FileCounter=FileCounter+1; 
        if exist(FileName,'file') 
                cube(:,:,FileCounter)= double(imread(FileName)); 
                disp(wavearray(FileCounter)); 
        end 
end 
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%******************************************************************* 
% Build image using SAM 
anpha=zeros(nr,nc); 
RefSpectrum=NanoSpectrum./Lampspectrum; 
for i=1:nr 
    for j=1:nc 
    PixelSpectrum(1,:)=cube(i,j,:); 
    PixelSpectrum(1,:)=PixelSpectrum(1,:)./Lampspectrum; 
anpha(i,j)=acos(sum(PixelSpectrum(1,:).*RefSpectrum)/sqrt(sum(RefSpectrum.^2)*sum(Pixel
Spectrum(1,:).^2))); 
    end 
end 
 
%******************************************************************* 
% Detecting NPs by set a threshold filter 
anpha2=anpha; 
theshold=mean(mean(anpha2)); 
for i=1:512 
    for j=1:512 
        if anpha2(i,j) >theshold; 
           anpha2(i,j)=theshold; 
        end 
    end 
end 
 
%******************************************************************* 
% Imaging and saving data 
imagesc(anpha2); 
colorbar 
imwrite(anpha2*256,'HyperIMG.tif'); 
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Appendix N. Determination of iron content of the NPs by visible spectroscopy 
Colorimetric analysis using spectrometer is a simple, fast, cheap, and reliable method. 
It can be used for determination amount of iron in samples [194]. The colorimetric analysis 
can provide us the ratio between weight of Fe and weight of NPs sample (mFe/mNPs) but it 
cannot be used to calculate RFe=Fe/(Zn+Fe) (mol/mol) directly, because there are amounts 
of other elements such as DEG, H20 in the sample. 
However, we can determine RFe=Fe/(Zn+Fe) (mol/mol) using colorimetric analysis by 
comparing with AAS data as the references because both of colorimetric analysis and AAS 
can give us the value of mFe/mNPs. We assume that RFe versus mFe/mNPs is a linear function 
(y=ax+b). We can determine the values for variables of this function by using linear fitting 
with the ASS data (see Figure N. 1). In our case, the values of variables are: a = 18, b= -
0.054, and the RFe can be estimated as Table N.1. 
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Figure N.1. Determination of relationship between RFe and mFe/mNPs. 
Table N.1. Estimation of RFe in samples 
Sample mNPs (mg) mFe (mg) mFe/mNPs RFe(mol/mol) 
DEG-0.05 1.2 0.0078 0.0066 0.064 
DEG-0.15 0.9 0.0116 0.0129 0.179 
DEG-0.35 0.5 0.0143 0.0286 0.461 
 
 
